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CHAPTER 1 
General Introduction 
Introduction 
Gonorrhoea is an infectious disease caused by Neisseria gonorrhoeae. Its 
uncomplicated form can be found in the urogenital tract, rectum and oro-
pharynx in both males and females. The disease is one of the sexually trans-
mitted diseases, and as a rule is transmitted via sexual intercourse. At this time, 
gonorrhoea is among the most notifiable infectious diseases in the world. 
Neisseria gonorrhoea 
In 1879 Neisser discovered the gonococcus (Neisseria gonorrhoeae) and 
identified it as the probable pathogen of gonorrhoea'. In 1885 Bumm suc-
ceeded in inducing gonorrhoea by inoculating pure cultured gonococci into a 
male urethra.' 
The bacterium is a species of the genus Neisseria of the family Neisseriaceae. 
The Neisseriae are non-motile, non-sporing, Gram-negative diplococci. The 
nutrient media used to culture gonococci must meet very specific require-
ments. They autolyse rapidly and their resistance to changes in physical and 
chemical conditions is low. 
Gonococci can be distinguished from other Neisseria species by sugar fer-
mentation tests and immunofluorescence techniques2 . Gonococci ferment 
only glucose, but not maltose, lactose and saccharose. Immunofluorescence 
techniques make use of specific antisera. On an agar medium, gonococcal 
strains can assume various colony types, the most important of which are T1, 
T2, T3 and T4 (Kellogg eta!. )3 • Cultivation of freshly isolated clinical material 
generally produces the small colony types T1 and T2. After non-selective 
cultivation these types change into T3 and T4. Whereas gonococci of colony 
types T1 and T2 cause gonorrhoea after intra-urethral inoculation of human 
volunteers, this cannot be achieved with T3 and T4 gonococci. 
Jephcott eta!. (1971)4 and Swanson eta!. (1971)5 independently demon-
strated pili on type 1 and 2 gonococci. These pili prove to play an important 
role in the attachment of gonococci to human cells'. The cell envelope of the 
gonococcus (figure 1) consists of a cytoplasmic membrane, a peptidoglycan 
layer and an outer membrane. There are indications that the gonococcus forms 
a capsule of polysaccharides outside the outer membrane 7• 8• 9 • 
Epidemiological investigation requires methods to establish the identity of a 
particular gonococcal strain. Catlin (1973) 10 described a typing system {auxo-
typing) which makes it possible to divide strains into groups on the basis of 
growth requirements. Johnston et al. (1976) 11 and Sandstrom and Danielsson 
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Fig. 1. Composition of the gonococcal cell wall. 
P ~ Pili 
O.M. = Outer membrane 
P.G. ~Peptide glycan layer 
C.M. = Cytoplasmic membrane 
p 
\ \ \ \ \ P.G. 
C.M. 
(1980) 12 described typing systems in which the compost!Jon of the outer 
membrane and of other surface proteins is regarded as characteristics of a 
strain. 
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CHAPTER 2 
Serological Tests for Detection of Gonorrhoea 
Although in the course of time many tests have been designed, we are still in 
need of a sensitive, specific serological test to detect all forms of gonorrhoea. In 
The Netherlands, the GCFT is as a rule used to detect gonorrhoea serological-
ly. It can be stated in general that the serological tests so far developed are 
unsuitable for detection of (usually recent) anterior urethritis in the male. The 
available tests are more suitable for detection of asymptomatic infections in 
females, who are an important source of new-infections. Serological tests are of 
great importance especially for gonorrhoea! infections associated with com-
plications, because in these infections the gonococcus involved can often not 
be cultured, while serological tests show a relatively high sensitivity. 
Whole cells, crude preparations and extracts were initially used as antigen in 
various serological tests, without much success or emulation (Table 1 )1· 23 In 
recent years, attempts have been made to enhance the sensitivity and specifi-
city of tests for detection of gonorrhoea, especially by using purified antigens 
(pili, outer membrane protein antigens) and by introducing advanced tech-
niques such as RIA and ELISA (Table 2)24•32• 
Crude antigen 
The GCFT using a crude antigen is the serological test so far most widely 
used in the diagnosis of gonorrhoea. The test was introduced in 1906 by Muller 
and Oppenheim, who prepared an unpurified antigen from a single strain; 
Teague and Torrey (1907) subsequently used antigen prepared from several 
strains'. This reaction is still being performed routinely in The Netherlands. 
The antigen used is a crude extract prepared from a single strain (Oliver). The 
test is inadequate due to low specificity but above all due to lack of sensitivity. 
If interpreted with care, this test can nevertheless be used as an indicator in the 
diagnosis of complicated gonorrhoea! infections. 
Gonococcal pili 
Buchanan eta!. (1973)24 described a RIA in which gonococcal pili are used 
as antigen and positive results are obtained in 85% of females with uncompli-
cated gonorrhoea; its specificity, moreover, proved to be very high. Subse-
quent investigators confirmed the antigenic properties of gonococcal pili in 
RIA, IHA and ELISA systems, but scored lower than Buchanan eta!. (Table 
2). A disadvantage of these tests is that antibodies to pili as a rule prove to be of 
the IgG class, and consequently persist longer. 
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Table 1 Serological tests for detection of gonorrhoea, using crude antigens 
Principal antigens used Test Sensitivity % Specificity % 
(control groups) 
Females with Males with un- Patients with 
uncompl. * GC compl. GC compl. GC 
Crude antigen suspension; 
polyvalent/monovalent GCFT_t~7, 29 8-88 13-50 44-95 89- 99 (blood donors) 
preparations 
Alkaline extract haemagglu- 49-84 23-77 - 80- 98 (nuns, children, 
sonicate; LPS* tination8- 10 pregnant women) 
Precipitins (LPS) precipi- 60 73-88 - 68-100 (pregnant women, fe-
tation11 -12 males, laboratory 
personnel) 
Crude sonicate floccula- 51-86 50-80 - 85- 96 (blood donors, nuns, 
fractions tion (incl. monks). 
micro )6, 13-15 
Whole gonococci IFA6, 16-20** 61-79 20-56 86 89- 98 (nuns, low-risk groups) 
Commercial antigen Gonosticon 61 11 - 75- 98 (low-risk groups) 
dry dot21, 22 
\ 
Soluble antigen RIA23 100 93 - 60- 80 (females, military per-
sonnet) 
* LPS = lipopolysaccharide. 
** IFA = indirect fluorescent antibody test. 
* (un)compl. ~ (un)complicated. 
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CHAPTER 3 
Aim and Design of the Study 
The studies described in the following chapters were performed in an 
attempt to contribute to a solution of the problems mentioned in chapter two. 
For the purpose of these studies, material had to be collected from patients and 
several techniques had to be developed. Material and techniques were then 
used to study a number of specific problems concerning the serological 
diagnosis of gonorrhoea.' 
1. Almost the entire material was collected from patients attending the 
STD clinic of the Rotterdam University Hospital Dijkzigt. Gonococci were 
isolated from all patients with gonorrhoea, and stored. Sera were collected 
from patients with and without gonorrhoea. The patients were divided into 
well-defined groups on the basis of history, sex and diagnosis. Blood samples 
were obtained on the day of the first examination (D 1) and on at least one 
other day (D2), generally 11-22 days after Dl. More than two sera were 
collected from some patients. 
2. For serodiagnostic purposes an ELISA was developed, using a purified 
gonococcal pilus preparation from a single strain as antigen. The sera were also 
submitted to two tests routinely used elsewhere: an IHA using a pilus antigen 
from another gonococcal strain (used at the Statens Seruminstitut, Denmark), 
and a GCFT using a crude extract from a single gonococcal strain as antigen, 
(used at the National Health Institute, Bilthoven, The Netherlands). 
3. The first objective of this study was to evaluate the sensitivity and 
specificity of the abovementioned ELISA as applied to sera from various 
groups of patients. After application of the IHA and the GCFT to the same 
sera, the results were compared with those of the ELISA. 
4. Next, the influence of the choice of gonococcal pilus antigen on the 
sensitivity and specificity of the serological test was studied. 
5. Finally, a study was made of the contribution of the ELISA to the 
diagnosis of gonorrhoea when this test was applied to females without com-
plaints who attended the STD clinic for examination. 
10 
CHAPTER4 
Material and Methods 
Isolation and Purification of Gonococcal pili 
Pili used in this study were isolated by two methods. In both cases we started 
with highly piliated gonococci of colony type 1 or 2. In the procedure described 
by Robertson et al. 1 , gonococci are homogenized and, after differential cen-
trifugation, purified over a caesium chloride gradient. In the procedure descri-
bed by Hermodson et al. 2 the gonococci are similarly processed but purified by 
precipitation with ammonium sulphate. Detailed descriptions of the two me-
thods follow. 
Method of Robertson et al.1 (modified by Oranje) 
Gonococci were cultured on Difco GC medium or Kellogg solid nutrient 
medium during 20 hours at 37'C in humid air containing 5% carbon dioxide. 
Colony types 1 and 2 were selectively transferred in further inoculations and 
stored at -70'C in aliquots filled with liquid Difco GC medium (without agar) 
to which 10% glycerol had been added. For the production of pili, gonococci 
from such an aliquot were cultured overnight and then checked for colony 
type. In the case of doubt the presence of pili was established electron-mi-
croscopically. The gonococci were then suspended in normal saline and the 
suspension was dripped onto plates (with a diameter of 9 em) and spread with 
the spatula (0.1 ml!plate = 109 gonococci/ml). Type 1 or 2 gonococci were 
harvested from 200 Difco GC medium or Kellogg solid nutrient medium 
incubated during 20 hours at 3rC in humid air containing 5% C02 (in a C02 
incubator type T 303, Assab, Sweden) and suspended in ice-cold (O'C) 0.01 M 
Tris HCl buffer pH 8.0. The harvest from 50-80 plates was suspended in 15 ml 
buffer. For release of the pili the gonococci were homogenized during 2 
minutes in an MSE homogenizer. Gram staining was used to check the sus-
pensions for possible contamination by other bacteria. To disaggregate the pili, 
5.1 g sucrose (1M) was added to 15 ml suspension. This mixture was briefly 
shaken on the vortex mixer, stored during 30 minutes at O'C, and homogenized 
during 15 seconds. The pili were then separated from the bacteria by centrifu-
ging them twice at 10,000 x g and twice at 15,000 x g. The two supernatants 
were combined and N aCl was added to a concentration of 1 M. The impure pili 
were sedimentated by centrifuging at 100,000 x g during 4 hours at 4'C. The 
sediment was resuspended in 0.01 M Tris HCl buffer pH 8.0, and caesium 
chloride was added to a concentration of 40% (w/v). The pili were then 
separated and treated with a Teflon homogenizer. Gradient centrifugation 
(100,000 x g) took place in a swing-out rotor during 48 hours at 4'C. A band 
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consisting of purified pili was obtained at a density of 1.30. Ultimately the 
concentrated pili were drained off by suction, centrifuged at 100,000 x g during 
3 x 1 hour at 4'C, and washed in PBS pH 7.8 to which 0.38 M NaCI had been 
added. The pili were stored in PBS pH 7.8 (0.02% w/v NaN3). The quality of 
the pilus preparation was visually checked electron-microscopically. If it was 
insufficiently pure it was rejected, or caesium chloride gradient centrifugation 
was repeated. 
Method of Hermodson et al.2 (modified by Reimann) 
Gonococci were cultured and checked for the correct type as in the above 
described method. The gonococci from 150 Kellogg plates were harvested in 
ice-cold (O'C) 0.01 M Tris HCI buffer pH 9.5. The harvest from 75 plates was 
suspended in 25 ml. The homogenization and the check-up by Gram staining 
were in accordance with the previous method. The pili were then separated 
from the bacteria by centrifuging suspensions at 12,000 x g during 10 minutes 
and at 50,000 x g during l.hour. After combining the supernatants in one 
cylinder (about 45 ml), the same volume of 20% saturated (NH4) 2S04 (ice-
cold, O'C) was added to precipitate the pili. This mixture had to be gently 
stirred during about 14 hours (overnight) at 4'C. The next day it was centri-
fuged at 30,000 x g during 15 minutes. The supernatant was carefully removed 
by suction. The pilus precipitate was re-suspended in 0.5- 1 ml 0.01 M Tris 
HCl buffer pH 7.0 (with 0.01 M NaN3 added) and stored at 4'C. The quality 
was checked electron-microscopically, and insufficiently pure pilus prepara-
tions were rejected. 
Characterization of pilus antigen 
Gonococci and pilus preparations were assessed electron-microscopically in 
a Philips EM300 microscope at the Department of Cell biology of the Erasmus 
University, with the technical assistance and advice of P. J. Visser. The samples 
to be tested were negatively stained with 2% sodium phosphotungstate pH 7.6 
(photograph 1 and 2) using carbon-impregnated collodium copper grids (mesh 
200). All pilus preparations were found to be slightly polluted by vesicles 
(possibly endotoxin blebs or cell membrane fragments). The protein content of 
the pilus preparation was determined according to Lowry et a!. 3 , using bovine 
serum albumin as standard. 
ELISA test principle 
The ELISA is a highly sensitive serological system in which an enzyme is 
linked to antibodies or antigens'· 5• Such an enzyme/ antibody or enzyme/ anti-
gen conjugate has both immunological and enzymatic activity. The reaction 
between antigen and antibody takes place on the wall of tubes and micro titre 
plates. The most widely used enzymes are peroxidase or alkaline phosphatase. 
A substrate suitable to the enzyme used is offered, and the ultimate result is a 
change of colour. The intensity of this change of colour can be determined with 
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Photograph 1: 
Electron micrograph of a highly piliated gonococcus, (colony type 2, strain 1443), 
negatively stained 23300 x. 
Photograph 2: 
Electron micrograph of gonococcal pili purified from strain 6650, 29300 x. 
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the naked eye or, more exactly and more objectively, by measuring the 
absorbance in a spectrophotometer'-
ELISA procedure 
The various steps of the procedure used in this study are schematically 
represented in figure 1. This is known as the indirect ELISA. 
Figure 1 Schematic representation of the ELISA 
~ 1) Pilus antigen adsorbed to carrier (polyvinylchloride) 
~<11 • .-----<811 2) Test serum with specific antibodies 
~·~·} 3) Goat antihuman immunoglobulin labelled with horseradish peroxidase. 
4) H20 2 plus OPD 
Discoloration in Orange 
5) Reading in spectrophotometer (492 nm) 
Reagents 
PBS pH 7.8: 10 tablets Dulbecco A were dissolved in 11 distilled water and 
autoclaved at 115'C for 10 minutes. One ampoule Dulbecco B was added to 
the solution after cooling. 
Sodium carbonate buffer: 35 ml 0.1 M NaHC03 , 65 ml 0.1 M Na2C03 and 
20 mg NaN3, adjusted to pH 9.6. 
Buffer pH 5.0: equal amounts of 0.2 M Na2HP04 and 0.1 M citric acid, 
adjusted to pH 5.0. 
Substrate solution: 40 mg orthophenylene diamine was dissolved in 100 ml 
buffer (pH 5.0) and 40 ~-tl 30% H 20 2 was added to the solution. 
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Assay procedure 
Coating with antigen: 
The pilus antigen required, expressed in 1-lg/ml protein3, was supplemented 
with sodium carbonate buffer pH 9.6 to a total volume of 2 ml in a small MSE 
65 tube. Immediately before use the antigen was sonicated in an ultrasonic 
disintegrator (8 micron, probe 3,3 mm) during 1 minute at 0°C. After sonica-
tion the antigen was further diluted to the concentration required in the test. 
This pilus antigen concentration was established by chessboard titration and 
varied from 2 !-lg to 6 1-lg protein/ml, dependent on the pilus batch. 
The microtitre plates were coated by depositing 50 Ill pilus antigen in each 
cup; incubation was carried out for 4 hours at 37°C in a water bath. All other 
incubations were carried out under the same conditions. After washing with 
PBS pH 7.8, 100 ftl1% bovine serum albumin was added and the plates were 
re-incubated for 30 minutes at 3rC to cover any free reaction sites. After 
further washing with PBS pH 7.8, the plates were stored at 4°C. 
Assay: 
Patient sera were diluted 1:100 in PBS pH 7.8, and 50 Ill aliquots of the 
diluted serum were added (in duplicate) to the cups and incubated for 45 
minutes at 37°C. The plates were then washed four times with PBS pH 7.8 
(plus 0.05% Tween 20), and 50 Ill of an optimal dilution of horseradish 
peroxidase-conjugated antihuman total immunoglobulin (Institut Pasteur) 
was added. The plates were then re-incubated for 45 minutes at 3rC and 
washed six times with PBS pH 7.8 (plus 0.05% Tween 20). After addition of 
50 ~tl substrate the plates were incubated for 50 minutes at 37°C. The reaction 
was stopped by adding 50 ~tl2M H 2S04 • A positive and a negative serum were 
included on each microtitre plate. A row of antigen controls (coated cups 
without serum) and a maximum colour control (conjugate plus substrate) were 
likewise included on each plate. 
Absorbance was read at 492 nm using a Multiskan (Titertek) spectro-
photometer, with reference to a row of blanks (antigen controls). 
Test conditions 
The optimal conjugate dilution was established by antigen conjugate titra-
tions in order to minimize non-specific coloration. 
The optimal antigen concentration was established exactly by performing 
the assay with a strongly positive, a weakly positive and a negative serum on 
cups coated with different antigen concentrations. 
The duration of passive adsorption ("coating") of the antigen to the poly-
vinylchloride microtitre plates (flat bottom PVC, Cooke microtitre system) 
was varied in time and temperature: 16 hours at4° and24, 6, 5, 4, 3 and2 hours 
at 37°C. These times were chosen in view of data from the literature' and for 
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practical reasons. Again, the three previously mentioned reference sera were 
used. The optimal coloration and change of colour took place between 3 and 5 
hours at 3rC. The "coating" time was set at 4 hours at 37"C. "After-coating" 
with 1% bovine serum albumin enhanced the evenness of coloration but to 
some extent also the background. 
The abovementioned antigen con jugate titration was repeated for each 
series of coated plates. The antigen-coated plates could be stored for 10 days at 
4°C after washing them once with PBS pH 7.8; longer storage entailed a 
gradual loss of quality. 
Reliability and precision of the ELISA results 
In an effort to establish the reliability and precision of the results in the test 
system, the following experiments were set up. 
1) The variation "within one micro titre plate" was examined by testing all 
cups of the plate with the same serum. 
2) The "day-to-day" variation was examined by testing simultaneously anti-
gen-coated microtitre plates daily with two sera. 
3) The variation between different coatings was examined by comparing the 
results obtained with 20 sera on plates with four different coatings: A, B, C 
and D. 
All these experiments were performed with the ELISA, using gonococcal pili 
1443 as antigen. All the results of these experiments were accounted for in the 
"results". 
re 1) Variation "within one plate" 
In early experiments, a positive serum was tested eight-fold in serial serum 
dilutions on the horizontal rows of a microtitre plate. 
Per vertical row (same serum dilution) the result was assessed qualitatively 
with the naked eye; four independent investigators assessed all rows as show-
ing no difference. 
In subsequent experiments this test was repeated in a serum with a high 
absorbance result; in view of the serum strength, this was done at serum 
dilution 1:400. The mean absorbance of eight determinations was 1.16, the 
standard error being 0.07 and the coefficient of variation being 6%. 
It can be concluded that variation "within one plate" was inconsiderable. 
re 2) Day-to-day variation 
Two sera were tested on microtitre plates on four consecutive days, the four 
microtitre plates having been coated simultaneously with the same antigen 
concentration. The first serum was pooled from some positive sera (P), and the 
second from negative and weakly positive sera (D). Absorbance results, stan-
dard errors and coefficients of variation of the sera are presented in table 1. 
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Table 1 Day-to-day variation in sera P and D 
Pool sera 
p 
D 
* mean absorbance. 
Serum dilution 1: 100 
rnA* SE CV% 
1.76 
0.75 
0.16 
0.18 
9 
24 
Serum dilution 1:200 
rnA SE CV% 
1.29 
0.58 
0.17 
0.11 
13 
19 
The coefficient of variation in the positive serum was less than 15%, and 
about twice that of variation "within one plate." In the serum with a low 
absorbance value the coefficient of variation was higher, the standard error 
remaining constant. 
re 3) Variation between different coatings 
The influence of different coatings on the absorbance result was measured in 
20 sera (dilution 1: 100). Of these 20 sera, nine had a mean absorbance of 1.50, 
seven one of 1.00-1.50 and four one of less than 1.00. Sera with a high 
absorbance value showed a low coefficient of variation (CV < 15% ). Inverse-
ly, sera with a low absorbance value showed a high coefficient of variation (CV 
? 30%). Thirteen of the sera showed a CV of less than 15%. The standard 
error was virtually the same in all the sera. The results are presented in table 2. 
Table 2 Influence of coating on the variation of the absorbance results in 20 tested sera 
(dilution 1:100) 
Coating 
A 
B 
c 
D 
A, B, C and D together 
CV% (median value) 
19 
12 
8 
13 
13 
To summarize: the coefficient of variation in sera with a high absorbance 
value was less than 15%, while sera with a low absorbance value showed 
coefficients of variation of30% or more. A striking feature ofthis experiment, 
too, was the constancy of the standard error (L. A = ± 0.15). There were 
virtually no differences in variation between this experiment and the "day-to-
day variation" experiment; the influence of different coatings was therefore 
small. 
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Conclusion from experiments 1 throngh 3 
These experiments demonstrate that the ELISA as performed in this study 
had a constant standard error (!'.A~± 0.15). This Jed to a low coefficient of 
variation at high absorbances, and to a high coefficient of variation at low 
absorbances. 
In view of these results we formulated as requirement for the definitive 
performance of the ELISA that the absorbance results may show a coefficient 
of variation of no more than 15%. In actual practice this meant that 5-10% of 
all assay runs had to be rejected. This requirement was not applied to sera with 
very low absorbance values (evidently negative). 
Choice of the breakpoint between positive and negative in the ELISA 
The determination of the breakpoint between positive and negative, and the 
problems this poses, are discussed in the appendix to chapter 5. 
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CHAPTER 5 
Enzyme-Linked lmmllliosorbent Assay (ELISA) 
Using Gonococcal Pili as Antigen: 
The value of testing consecutive serum samples obtained from 
defined patient groups attending an STD Clinic in Rotterdam. 
Arnold P. Oranje*, Anne! de Roo**, Ernst Stolz* and Marc F. Michel** 
Department of Dermatology and Venereology*, 
Clinical Microbiology and Antimicrobial Therapy**, Erasmus University 
Rotterdam. 
Summary 
An ELISA system was developed which uses gonococcal pili as antigen. The 
value of this test was studied by applying it to paired serum samples (the first 
taken at the first examination, and the second 11-22 days later) from certain 
patients. The patient groups studied were strictly defined and selected. Par-
ticular attention was paid to the contribution of the examination of the second 
sample to the test sensitivity of the assay. Testing of the second sample did not 
add to test sensitivity in asymptomatically infected females. For males and 
females with uncomplicated gonorrhoea, however, the testing of a second 
paired serum sample led to a marked increase of sensitivity; this was also 
observed for infected males with 5-30 days of symptoms. 
Maximum sensitivity was 53% in the total group of infected females, 61% in 
the asymptomaticfemales, 41% in the total male group, and 62% in the males 
with 5-30 days of symptoms. 
When applied to sera from patients with oropharyngeal gonorrhoea the 
ELISA attained up to 96% sensitivity. This study confirms previous findings 
that serological tests using gonococcal pili as antigen are unsuitable as a 
diagnostic tool unless oropharyngeal gonorrhoea or complicated gonococcal 
infections are suspected. 
Introduction 
Numerous serological tests for detection of gonorrhoea have been descri-
bed'. The best known and most widely used of these is the GCFT 2 •6 This test, 
however, has the disadvantage of being neither very sensitive nor very specific. 
1. To be published as an abstract in the Proceedings of the 224th Meeting of the 
Netherlands Society for Dermatology and Venereology, Rotterdam. February 
1982. 
2. Complete paper accepted for publication in the European 1. Sex. Transm. Dis. 
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Buchanan et al.' described a RIA which uses gonococcal pili as antigen; they 
attained a high level of sensitivity with this test, especially in asymptomatically 
infected females (89%). Oates eta!.', Reimann eta!!, Brinton et al. 10 , and 
Young and Low11 confirmed the excellent antigenic properties of gonococcal 
pili in a RIA', an IHA9 and an ELISAI0.1I. 
This article presents results obtained with an ELISA system which uses pili 
from a single strain of Neisseria gonorrhoeae as antigen. This system was 
applied to sera from selected, well-defined patient groups with and without 
gonorrhoea, attending an STD clinic in Rotterdam. Special attention was paid 
to the contribution to the sensitivity of the assay made by examination of a 
second, consecutive serum sample taken 11-22 days after the first examina-
tion. 
Material ami Methods 
Patients 
Between September 1977 and July 1978, sera were obtained from patients 
with and without gonorrhoea attending an STD clinic at the University Hos-
pital in Rotterdam. Samples were taken from cervix, urethra, rectum and 
oropharynx of females and from urethra, oropharynx and rectum (only if 
indicated) of males. Each specimen was cultured on selective Thayer-Martin 
medium12 and on chocolate agar medium without antibiotics. Suspected 
oxidase-positive colonies were identified as gonococci by Gram stain and sugar 
fermentation reactions. If cultures of first and a second examination (after 1-2 
weeks) were negative, the patient in question was considered not to be suffe-
ring from gonorrhoea. A positive Gram stain and negative cultures for gonor-
rhoea were found in only a few patients, who were excluded from this study. 
All patients were subjected to routine tests for detection of other STD as 
described by Stolz13 
Generally patients were included in the study only if two consecutive serum 
samples could be obtained at an interval of 11-22 days. They were then 
assigned to the following groups: 
Patients with gonorrhoea 
females with uncomplicated urogenital/rectal gonorrhoea ( n = 104 ), subdi-
vided into those with asymptomatic (n=56) and those with symptomatic 
infections (n=48); 
males with uncomplicated urogenital/rectal gonorrhoea (n=l29), sub-
divided into those with 1-4 days of symptoms (n=79), those with 5-30 days 
of symptoms (n=34), and those who fell into neither of these two groups 
(n=16). 
patients with oropharyngeal gonorrhoea (n=24) 
Patients without gonorrhoea: 
females attending the clinic for an STD check (n=28); 
- female prostitutes (n=21); 
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- males attending the clinic for an STD check (n=72); 
- males with non gonococcal urethritis (n=83). 
Control sera were obtained from 119 blood donors (46 females, age range 
19-65 years, and 73 males, age range 20-62 years) and 58 children (25 girls 
and 33 boys aged between 10 and 12 years). 
Sera from blood donors were kindly donated by Dr F. Kothe of the Rot-
terdam Transfusion Service, and sera from children by Prof. Dr H. A. Val-
kenburg and Dr F. Klein of the Department of Epidemiology, Erasmus Uni-
versity Rotterdam. The children in question were all healthy inhabitants of 
Zoetermeer (a suburb of The Hague). 
Buffers and growth media 
GC medium: Difco medium, 36 g/1, supplemented with 2% Isovitalex. 
Liquid medium: 4.5 g proteose peptone, 0.3 g K2HPO,, 1.5 g NaCl, 30 ml 
glycerol, and 300 ml distilled water. (For further details see chapter 4 page 14 .) 
Gonococcal strain 
A stable highly piliated strain, 1443, isolated in Rotterdam in 1976, was 
used for pilus production. 
Preparation of gonococcal pilns antigen 
Type 2 gonococci of strain 1443 were cultured on solid growth media. The 
inoculated plates were incubated at 3rC for 18 to 20 hours in moist air 
containing 5% C02 (in a C02 incubator type F 303, Assab, Sweden). The pili 
were purified as described by Robertson et al.l' (with some minor modifica-
tions). For details see chapter 4, page 11-12. 
Characterization of pilns antigen (chapter 4, page 12)15 • 
ELISA procedure 
Coating and assay: see chapter 4, page 14-15. 
Reading: All sera were tested only at dilution 1:100. Absorbance was read 
at 492 nm using a Multiskan (Titertek) spectrophotometer, with reference to 
the row of blanks. Readings were classified as follows: A>0.90 "positive", 
absorbance between 0.80 and 0.90 were classified as "doubtful", and those 
between 0.90 and 1.00 as "weak-positive". All sera from the children tested, 
had absorbal)ces below 0.90. 
The coefficient of variation within the test (plate to plate) and from test to 
test (day to day) was less than 15%; only for undoubtedly negative sera was it 
higher. 
The first and second serum samples were tested as a pair; all sera including 
the controls, were tested in duplicate. 
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Statistical analysis 
Fisher's test16 was used to compare the percentages of positive results in two 
different patient groups; the two-sided tail probability was computed in the 
way proposed by Cox and Hinkley 17• 
McNemar's test 16 was used to compare the percentages of positive results in 
two consecutive serum samples from the same patients. 
Results 
Patients with uncomplicated gonorrhoea 
Table 1lists the percentages of ELISA-positive sera in the various groups of 
patients with gonorrhoea. In the group of females with uncomplicated gonor-
rhoea (n= 104), 45% of the first serum samples and 53% of those taken 11-22 
days later were positive, the difference being nearly significant. When these 
104 females were subdivided into those with asymptomatic infection (n=56), 
and those with symptomatic infection ( n =48), the sensitivity of the ELISA was 
-as expected- higher in the former group (D 1 =57%, D2 = 61 %) than in the 
latter (D1= 31%, D2 = 44%). The difference between the two D 1 values is 
significant. 
For females with asymptomatic infection the sensitivity was not significantly 
higher in the second serum sample than in the first one. In those with symp-
tomatic infection there was a difference in sensitivity, but not a significant one. 
Cumulative sensitivity was 58% in the total group offemales with uncompli-
cated gonorrhoea, the corresponding figures in the subgroup with asymp-
tomatic and that with symptomatic infection being 66% and 48% respectively. 
For males with uncomplicated gonorrhoea (n = 129), 32% of the first serum 
samples and 41% of those taken 11-22 days later were positive. The males 
with uncomplicated urogenital/rectal gonorrhoea were subdivided into a 
group with 1-4 days of symptoms (n=79), one with 5-30 days of symptoms 
(n=34), and a small residual group with more than 30 days of symptoms or 
with no established record of symptoms (n= 16). The sensitivity of the ELISA 
was higher in the group with 5-30 days of symptoms (D 1 = 44%, D2 = 62%) 
than in that with 1-4 days of symptoms (D 1 = 25%, D 2 = 34%). The difference 
between the two D 1 values is nearly significant and that between the two D2 
values is significant. In the total group of males with uncomplicated gonor-
rhoea and in those with 5-30 days of symptoms the sensitivities on D 2 were 
significantly higher than those on D 1• Cumulative sensitivity was 47% for 
males with uncomplicated gonorrhoea, the corresponding figures in the sub-
group with 1-4 days of symptoms and in that with 5-30 days of symptoms being 
42% and 62% respectively. 
Oropharyngeal gonorrhoea 
Paired serum samples were obtained from 24 patients in this group. The 
ELISA results in this group are presented in table 2: 21 of the 24 sera were 
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Table 1 Sensitivity of ELISA, using gonococcaL pili 1443 as antigen, in different patient groups on date of first examination (DJ) 11-22 
days after first examination (D2) and on D1 and/or D2 (cumulative) 
Patient groups Sensitivity % 
D, D, Cumulative 
1. FEMALES with current GC (n~104) 
a. asymptomatic uncomplicated urogenital/rectal GC (n~56) 
b. symptomatic uncomplicated urogenital/rectal GC (n=48) 
2. MALES with current GC (n~129) 
a. with uncomplicated urogenital/rectal GC with complaints 
for 1-4 days (n~79) 
b. with uncomplicated urogenital/rectal GC with complaints 
for 5-30 days (n~34) 
c. others (n~16) 
45 53 
57 61 
31 44 
32 41 
25 34 
44 62 
37 31 
Significance of differences in sensitivity on D1 and D2 between the different groups, assessed by Me Nemar's test 
Patient groups* 
Group 1 
Group 2 
Group 2b 
Comparison of D 2 with D 1 
0.05<p<O.l 
p<0.05 
p<0.05 
Significance of sensitivity differences observed between the various groups, as assessed by Fisher's test 
Groups compared 
la and lb * 
2a and 2b 
* only relevant groups are mentioned. 
D, 
p ~ 0.01 
p ~ 0.07 
D, 
ns 
p ~ 0.007 
58 
66 
48 
47 
42 
62 
37 
positive on Db and 23 of the 24 sera were positive on D2 (6-22 days after D 1). 
Test sensitivity was therefore 87% on Db 96% on D 2 and cumulative 100%. 
Table 2 Sensitivity of ELISA using gonococcal pili 1443 as antigen in patients with 
oropharyngeal gonorrhoea, on date of first examination (D 1), 6-22 days after 
first examination (D 2) and on D 1 and/or D2 (cumulative) 
Patient groups 
Total group 
-females (n~15) 
- males (n~9) 
* Absolute numbers are given in brackets. 
Patient groups without gonorrhoea 
D, 
87 (21)* 
87 (13) 
89 ( 8) 
Sensitivity % 
D, Cumulative 
96 (23)* 100 (24) 
93 (14) 100 (15) 
100 ( 9) 100 ( 9) 
Table 3 shows that test specificity in patients without gonorrhoea varied 
widely from group to group. 
The highest specificity was found in males who attended the clinic for an 
STD check (D 1 ~ 87%, D2 ~ 90%), and it was nearly as high in the males with 
NGU (D 1 ~ 84%, D2 ~ 83%). 
Specificity in females visiting the clinic for an STD check was somewhat 
lower (D 1 ~ 75%, D2 ~ 82%) and prostitutes attending the clinic showed the 
lowest specificity (D 1 ~ 52%, D2~ 38%). 
Table 3 Specificity of ELISA, using gonococcal pili 1443 as antigen, in different patient 
groups on date of first examination (D1), 11-22 days after first examination 
(D 2) and on D1 and/or D2 (cumulative) 
Patient groups Specificity % 
D, D, Cumulative 
1. FEMALES without current GC (n~49) 
a. requesting an STD check (n~28) 75 82 64 
b. prostitutes (n~21) 52 38 29 
2. MALES without current GC (n~155) 
a. requesting an STD check (n~72) 87 90 85 
b. with NGU (n~83) 84 83 82 
Group la scored significantly higher than group lb on D2 (p = 0.003 Fisher's tpst); the 
cumulative specificity difference between these groups is significant too (p = 0.02 
Fisher's test). 
24 
Cumulative specificity was appreciably lower in the groups with cultures 
negative for gonorrhoea: 64% in females and 85% in males visiting the clinic 
for an STD check. The prostitutes showed a particularly low cumulative 
specificity: 29%. Cumulative specificity in males with NGU pratically equalled 
that in males requesting an STD check: 82% versus 85%. 
Other groups 
As already mentioned, sera from 119 blood donors and from 58 children 
aged 10-12 years were included in this study. No positive results were obtained 
in either of these groups. Two doubtful results were read in the blood donor 
groups, and four in the children. Of the two sera from children with menin-
gococcal sepsis, one was strongly positive (A=l.SO), while the other was 
negative (A=0.34). 
Discussion 
The ELISA originally developed by Engvall and Perlman" and Van Wee-
men and Schuurs19 has proved to be of value in various serological studies. Not 
only does this system permit measurement of very low antibody levels but it 
also has the advantage of lending itself to a high degree of mechanization, thus 
avoiding human errors and possible faulty readings20 • 
Our version of the ELISA, using gonococcal pili as antigen, gave the best 
results in infected females (particularly in those with asymptomatic infections), 
in patients with oropharyngeal gonorrhoea and in patients with complicated 
gonorrhoea! infections (see chapter 6). 
The observed sensitivities and specificities would seem to warrant the con-
clusion that the ELISA in its present form is not suitable as an aid in the 
diagnosis of gonorrhoea in a patient population of an STD clinic. The short 
incubation time of gonorrhoea is probably the principal cause of the poor 
sensitivity of the assay. Serological gonorrhoea tests such as the ELISA are 
generally suitable for case detection in patients suffering from non-genital 
localized STD. 
It is important that a serological test is both sensitive and specific. For the 
purpose of case detection and screening, moreover, it is important (for prac-
tical and economic reasons) that only one blood sample need be examined. 
With the ELISA we used, we found that in the second serum sample tested the 
sensitivity was higher in certain groups of patients, e.g. females with symp-
tomatic gonorrhoea, and all male patients examined. In the latter total group 
the increase in sensitivity was significant. However, most males suffer from 
symptomatic gonorrhoea of short duration, which can be diagnosed quite well 
on the basis of the clinical signs and hardly requires the use of a serological test. 
The results obtained in asymptomatically infected females clearly show that 
the use of two serum samples does not ensure a significantly higher score than 
the use of one sample in tracing unnoticed gonorrhoea of long duration. 
The diagnosis of complicated gonococcal infections and oropharyngeal 
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gonorrhoea is a potential area of application for this ELISA. In oropharyngeal 
gonorrhoea we achieved a very high sensitivity. 
Taking the results on D 1 and on D2 cumulatively, we find that sensitivity 
increases in all groups, whereas specificity decreases (as it can be expected to 
do). 
We think that, in the ELISA performed by us goncoccal pili may cross-react 
with antibodies evoked by other species of Neisseria. Four of the 58 sera from 
children showed absorbances which we classified as "doubtful". Moreover, the 
ELISA gave a strong positive result with one of the two sera from children with 
meningococcal sepsis. Buchanan et al.' likewise found increased levels of 
antibodies against gonococcal pili in three adult patients with meningococcal 
infections. Such cross-reactions with meningococcal antibodies are a well-
known phenomenon in serological tests for gonococcal antibodies 1o, 21 • 22 . 
In the ELISA we use antihuman total immunoglobulin-labelled horseradish 
peroxidase as conjugate. The choice of immunoglobulin class-specific conju-
gates might make it possible to distinguish between recent and previous 
gonorrhoea, but unfortunately we were unable to measure any antibody 
response of significance with antihuman IgA and IgM conjugates. Only a few 
of the sera of 79 males with recent uncomplicated gonorrhoea showed an IgM 
response (unpublished data). The immune response to gonococcal pili in 
human beings is dominated by IgG antibodies, as previously also found by 
Reimann et a!. 9 
It might be possible to enhance the sensitivity of the ELISA by adding one or 
more pilus antigens to the present pilus preparation. 
Given a positive ELISA result, a bacteriological culture should always be 
made before treatment is instituted. It is also important to question the patient 
about a possible history of gonorrhoea, for a positive result could also be due to 
previous gonorrhoea (whether treated or not). 
The ELISA is a suitable tool for the diagnosis of oropharyngeal gonorrhoea 
and complicated gonococcal infections. In the lastmentioned group it is not 
always possible to obtain a positive gonococcal culture and in such cases it 
would be justifiable to give treatment solely on the basis of a positive serolog-
ical test. 
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Appendix 
There are two methods of interpreting the result of a serological assay. The 
first calls for determination of a breakpoint for the distinction between a 
positive and a negative result. The breakpoint is related on rather arbitrary 
grounds to the study of a reasonable number of control sera. In the ELISA 
system the breakpoint can be expressed in several ways, e.g. as a titre of a 
conventional series of serum dilutions, as the ratio between a positive and a 
negative result, and by using a breakpoint in the reading of the colour intensity 
at a particular serum dilution 1• 
The second method interprets the test on the basis of disease prevalences 
expected a priori or a posteriori in certain patient populations2 
This study has opted for a system in which the absorbance values of sera are 
determined at one fixed dilution of 1:100. Sensitivity and specificity data 
related to a fixed breakpoint, however, do not give sufficient insight into the 
effectiveness of a test in certain patient populations. 
A serological test can be used for screening or case-detecting purposes; the 
purpose for which a test is used determines in part how many false positive 
and/ or false negative results will be accepted, i.e. where the breakpoint be-
tween positive and negative is set. The purpose of this discussion is to gain 
more insight into the effectiveness of an ELISA with gonococcal pili 1443 as 
antigen as screening or case-detecting test for gonorrhoea. To achieve this, 
the results obtained in patient populations with and without uncomplicated 
gonorrhoea were first interpreted in relation to three absorbance values: A ;;. 
0.80, A;;. 0.90 and A;;. 1.00. Next, the possible test results in three imaginary 
population groups or patient populations with gonorrhoea prevalences of 
0.1 %, 3% and 30% are discussed. Sensitivity, specificity and predictive values 
of positive and negative test results are terms used in the interpretation of the 
data. 
Patients with nncomplicated gonorrhoea 
Table 1lists the percentage of positive sera obtained from a number of males 
and females with uncomplicated gonorrhoea when different breakpoints are 
used in the interpretation of the ELISA. As expected, sensitivity increased 
when the breakpoint was lowered. The highest sensitivity was attained in 
females with uncomplicated gonorrhoea: 56% at A ;;. 0.80. 
Patients without gonorrhoea 
Table 2 indicates the specificity of the test in a number of males and females 
without gonorrhoea who attended an STD dinicfor a check-up. The specificity 
logically decreased when the breakpoint was lowered. The specificity was 
lowest in the group of females (n=28): 57% at A;;. 0.80. At that level it was 
still high in the group of males (n=72): 83%. 
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Table 1 The influence of different breakpoints on the sensitivity of the ELISA using 
gonococcal pili 1443 as antigen in patients with uncomplicated gonococcal 
infections attending an STD clinic 
Sensitivity % 
Patient groups 
A :;, 0.80 A :;;,0.90 A :;, LOO 
L FEMALES with current GC 
(n = 104) 56 45 41 
2. MALES with current GC 
(n = 129) 39 32 22 
Results relate to sera obtained on the day of the first examination. 
Table 2 The influence of different breakpoints on the specificity of the ELISA using 
gonococcal pili 1443 as antigen in patients without current gonococcal infec-
tions attending an STD clinic, and in two control groups 
Specificity % 
Patient groups 
A;;;, 0.80 A;;;, 0.90 A:;, LOO 
L FEMALES without current GC, 
with request for STD check-up 
(n = 28) 57 75 89 
2. MALES without current GC, 
with request for STD check-up 
(n = 72) 83 87 94 
3. BLOOD DONORS (n = 119) 98 100 100 
4. CHILDREN aged 10-12 years (n = 58) 93 100 100 
Results relate to sera obtained on the day of the first examination. 
Blood donors and children 
Table 2 also lists the results obtained in 119 blood donors and 58 children 
aged 10-12 years. At breakpoint A ;;;, 0.80, the specificity was 98% in the 
blood donors and 93% in the children. At the other breakpoints the specificity 
attained a value of 100%. 
Predictive value of the ELISA in different population groups and patient 
populations 
Table 3 lists the predictive values of a positive and a negative test result. As an 
example, the calculations on a female population with a prevalence of 9.1% at 
breakpoint A :;, 0.80 will be discussed in detail. 
A population with a gonorrhoea prevalence of 0.1% (e.g. the entire Neth-
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Table 3 Predictive values of a positive and a negative test result at different gonorrhoea 
prevalences 
Breakpoint 
Prevalence Sex 
A;;, 0.80 A ;;, 0.90 A ;;, 1.00 
PV(+) PV(-) PV(+) PV(-) PV(+) PV(-) 
0.1% F* 0.03 1.00 1.00 1.00 1.00 1.00 
M 0.02 1.00 1.00 1.00 1.00 1.00 
3% F 0.04 0.98 0.05 0.98 0.10 0.98 
M 0.07 0.98 0.07 0.98 0.10 0.97 
30% F 0.36 0.75 0.44 0.76 0.61 0.78 
M 0.50 0.76 0.51 0.75 0.61 0.74 
* F = female, M = male. 
erlands population, or females who undergo an abortion) is a low-risk group3 • 
The blood donors can best serve as a measure of the specificity in this popula-
tion. At A;;, 0.80, sensitivity is 56% and specificity is 98% (table 1 and 2). Let 
the number of females examined be 100.000, then 100 of them are suffering 
from gonorrhoea. Of these 100 females with gonorrhoea, 56 have a positive 
and 44 have a negative test. The 99.900 females without gonorrhoea include 
97.902 with a negative and 1998 with a positive test. Of the 56+ 1998 = 2054 
with a positive test, 56 have gonorrhoea, i.e. PV( +) = 56/2054 = 0.03. Ofthe 
44 + 97.902 = 97, 946 females with a negative test, 97,902 are free from 
gonorrhoea, i.e. PV(-) = 97.902/97.946 = 1.00. More or less the same figures 
apply to the males. Both in the males and in the females, the predictive values 
at A;;, 0.90 and A;;, 1.00 are virtually the same: 1.00 for a positive and 1.00 
for a negative result. 
The predictive values for populations with gonorrhoea prevalences of 3% 
and 30% are calculated in exactly the same way and are likewise listed in table 
3. In populations with a prevalence of 30% (as can be expected at an STD 
clinic) the test is unsatisfactory at A;;, 0.80 and A;;, 0.90. Only at A;;, 1.00 do 
the predictive values begin to assume an acceptable level: at this absorbance 
value the predictive value of a positive result is 0.61, while that of a negative 
result is 0.78 in females and 0.74 in males. This implies that a positive test 
result in females is correct in 61% of the cases, but incorrect (false positive) in 
39%. A negative test result is correct in 78% of the cases, but incorrect (false 
negative) in 22%. 
If at an STD clinic 200 female patients are examined with the aid of the 
ELISA (A ;;, 1.00), then 60 females (30%) can be expected to suffer from 
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gonorrhoea and 140 can be expected to be free from it. The ELISA result will 
therefore be positive in [0.41 (sensitivity) x 60 = 25] + [0.11 (!-specificity) x 
140 = 15] = 40 cases, and negative in 160. Of these results, 15 are false 
positive and 35 are false negative. This means that 50 (25%) of the 200 serum 
samples examined have given rise to an erroneous diagnosis or postulate. 
Galen and Gambino' formulated the following criteria for serological tests 
used in screening for gonorrhoea: sensitivity should be 80% or higher, specifi-
city should be 99% or higher, and no positive results should be found in 
patients with a history of gonococcal infection. 
The results clearly show that the ELISA using gonococcal pili 1443 as 
antigen is not suitable as a screening test in groups with a low gonorrhoea 
prevalence of0.1% or 3%. In a population with a high gonorrhoea prevalence 
of 30% (as can be expected in patients attending an STD clinic) the test is not 
satisfactory with A> 0.80 or A ;;, 0.90 as breakpoint absorbance value. At a 
breakpoint of A ;;, 1.00 the predictive values of the assay begin to attain 
acceptable levels in such a population, albeit that the assay result is still 
erroneous- i.e. false negative or false positive- in 25% of the cases. It should 
be borne in mind, moreover, that the sensitivity of the assay diminishes 
markedly at absorbance value A ;;, 1.00. In order to ensure nevertheless a 
reasonable balance between sensitivity and specificity, the following com-
promise was accepted. The breakpoint absorbance value was set at A;;, 0.90. 
Results with absorbance values 0.90 ,;; A< 1.00 were called weakly positive. 
At results with absorbance values 0.80 ,;; A < 1.00, the assay should be 
repeated in a fresh serum sample from the patient in question. 
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Summary 
Three serological tests for detection of gonococcal antibodies were com-
pared: an ELISA, an IHA and a GCFT. The ELISA was performed with 
gonococcal pili of a Rotterdam strain (1443), the IHA with pili of an American 
strain (2686, Buchanan), and the GCFTwith whole gonococci of a single strain 
( 46695, Oliver). The tests were applied to sera from several groups of Dutch 
patients. Serum samples were taken at the first examination (D 1) and generally 
11-22 days later (D2). 
The ELISA and the IHA were far more sensitive than the GCFT. The 
specificities of the tests were virtually equal in low-risk groups, but in high-risk 
groups the GCFT seemed slightly more specific. The ELISA and the IHA 
virtually did not differ in sensitivity and specificity. Maximal sensitivity for 
females with uncomplicated gonorrhoea was 53% for the ELISA, 58% for the 
IHA and 22% for the GCFT. The corresponding sensitivities in asymptomati-
cally infected females were 61%,63% and 21%, respectively. In the infected 
1. This chapter has been accepted for publication in shortened version in the Brit. 1. 
Vener. Dis. 
2. Presented at the meeting of the Netherlands Society for Microbiology Maastricht, 
May 1982. 
3. To be published as an excerpt in Antonie van Leeuwenhoek. 
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males with 5-30 days of symptoms the sensitivities were practically as high as 
those in the asymptomatically infected females. Maximal sensitivity for males 
with uncomplicated gonorrhoea was 41% for the ELISA, 50% for the IHA 
and 14% for the GCFT. 
The agreement between ELISA and IHA for patients with uncomplicated 
gonorrhoea was surprisingly not very high (kappa = 0.44), but as could be 
expected the agreement between GCFT and the two pilus assays was decidedly 
less (kappa = 0.26 and 0.20). The highest sensitivities were obtained with all 
three tests when they were applied to sera from patients with oropharyngeal 
gonorrhoea and complicated gonococcal infections. Again the ELISA and the 
IHA were more sensitive than the GCFT. 
In their present form, serological tests using gonococcal pili as antigen are of 
value as a diagnostic tool only in cases of suspected gonococcal complications. 
The value of the GCFT, described here, is very limited. 
Introduction 
The most interesting gonococcal ar.~igens for use in serological tests and 
application as vaccine are at this time pili and outer membrane protein com-
plexes1·5 Buchanan et aL (1973)2 were the first to publish promising results 
obtained with a RIA using gonococcal pili of strain 2686 (USA) as antigen. In 
sera from males and females with uncomplicated gonorrhoea, the sensitivity 
was 50% and 86%, respectively. 
Reimann et aL 6 obtained almost equally good results with an IHA using a 
mixture of gonococcal pili of two strains. 
We developed an ELISA in which gonococcal pili of a Rotterdam strain 
(1443) are used as antigen7 
This paper compares the results of the ELISA with those of the IHA using 
gonococcal pili of Buchanan's strain 2686, and with the GCFT routinely used 
in The Netherlands, in which whole gonococci of a single strain (Oliver) are 
used as antigen. 
Material and Methods 
Patients 
For details see chapter 5, page 20-21 s, 9 
Generally patients were included in the study only if two consecutive serum 
samples could be obtained at an interval of 11-22 days. They were then 
assigned to the following groups: 
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Patients with gonorrhoea 
females with uncomplicated urogenital/rectal gonorrhoea (n=l04). 
males with uncomplicated urogenital/rectal gonorrhoea (n=129). 
patients with oropharyngeal gonorrhoea (n=33) 
patients with complicated gonococcal infections (n=ll). 
Six of the patients were suffering from a disseminated gonococcal infection, 
one from bartholinitis, three from epidydimitis and one from a rectal abcess. 
Patients without gonorrhoea: 
females attending the clinic for an STD check (n=28); 
female prostitutes (n=21); 
males attending the clinic for an STD check (n=72); 
males with NGU (n=83). 
All patients were also asked whether they had previously contracted gon-
orrhoea; the various groups defined above could thus be further subdivided 
into those with a positive and those with a negative history of gonorrhoea. 
Control sera were obtained from 119 blood donors and 58 children aged 
between 10 and 12 years. 
ELISA 
The preparation of the gonococcal pilus antigen of strain 1443 (Rotterdam) 
and the procedure of the ELISA have been previously described7 Pilus 
antigen was purified according to the method of Robertson et al10 Serum 
samples which showed an absorbance ~ 0.90 were regarded as positive. (See 
chapter 4 and 5 for more details.) 
IHA 
The IHA was carried out as previously described by Reimann and Lind11 , 
using purified gonococcal pili of Buchanan's strain 2686 (USA) as antigen. 
Pilus antigen was purified according to the method of Hermodson et aP 2 • The 
titre of a given serum specimen was recorded as the reciprocal value of the 
lowest serum concentration giving a positive reaction. Titres ~ 40 were con-
sidered to be positive. 
GCFT 
The GCFT was performed as a mechanized microtechnique using Ames 
Autotiter instrument. Briefly, 0.05 ml inactivated serum was automatically 
added to the U-shaped cups of clear Conphar trays and diluted in two-fold 
dilutions from undiluted to 1 : 512 in 0.85% saline. Antigen (0.025 ml) and 
complement (0.05 ml) were then added to each cup and the reagents were 
incubated overnight at 4°C. The next morning, 0.025 ml each of amboceptor 
and 2% v/v sheep red blood cells suspended in saline were automatically 
dispersed into each cup. The trays were shaken and incubated at 37"C for 
1 hour. The titre was read as the highest dilution giving 100% inhibition of 
lysis, if the control cup showed 100% haemolysis. Serum showing less than 
100% haemolysis in the control cup was regarded as anticomplementary. 
About 5% of the sera in this patient material were anticomplementary and 
thus could not be read. 
The antigen used in the GCFT test was prepared from Neisseria gonorrhoeae 
strain 4669 5 (Oliver) by ultrasonic treatment of whole organisms suspended in 
saline13 . 
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Statistical analysis 
Fisher's test14 was used to compare the percentages of positive results in two 
different patient groups; the two-sided tail probability was computed in the 
way proposed by Cox and Hinkley". McNemar's test14 was used to compare 
the percentages of positive results in two consecutive serum samples from the 
same patients. The coefficient kappa16• 17 was used to measure the agreement 
between two serological tests. Kappa equals zero under statistical indepen-
dence and kappa equals one when there is perfect agreement. 
Results 
Patients with uncomplicated gonorrhoea 
Table 1 lists the percentages of positive sera in the ELISA, IHA and GCFT 
in patients with uncomplicated gonorrhoea. 
Of the sera obtained for females with uncomplicated gonorrhoea ( n = 104). 
45% were positive in the ELISA, 58% in the IHA and 21% in the GCFTon 
the day of the first examination (D 1). The corresponding sensitivities of the 
sera obtained 11-22 days later (D2) were 53%, 54% and 22%, respectively. 
When D 2 is compared with Db a nearly significant increase in percentage of 
positive sera is observed only in the ELISA. No significant differences in 
sensitivity are found between ELISA and IHA. The difference of both tests 
from the GCFT, however, is significant both on D 1 and on D 2 • 
For females with asymptomatic infections (n=56), the sensitivities of 
ELISA, IHA and GCFT on D 1 were 57%, 63% and 21%, respectively, versus 
61%, 55% and 18%, respectively, on D 2. Comparison of sensitivities on D 2 
with those on D 1 reveals no significant differences for any of the three tests. In 
fact the IHA and GCFT had lower sensitivities on D2 • ELISA and IHA show 
no significant difference in this group. The difference between these two tests 
and the GCFT, however, is again significant both on D 1 and on D2• 
For females with symptomatic infections the respective sensitivities of 
ELISA, IHA and GCFTwere 31%,52% and 21% on D 1 and 44%,52% and 
27% on D 2• ELISA and IHA sensitivities differed significantly on D1 but not 
on D 2 . ELISA and GCFT differed significantly on D2 but not on D 1• IHA and 
GCFT differed significantly both on D 1 and on D 2 • 
ELISA and IHA sensitivities were both higher in the group of asymptomati-
cally infected than in that of symptomatically infected females. This does not 
apply to the GCFT. In fact, on D 2 the sensitivity in the asymptomatic was lower 
than that in the symptomatic group (18% versus 27%). Only in the ELISA on 
D 1 did the sensitivity of these two groups differ significantly. 
Of the sera obtained for males with uncomplicated gonorrhoea (n=129), 
32% were positive in the ELISA, 36% in the IHA and 10% in the GCFT. The 
corresponding sensitivities on D 2 were 41%, 50% and 14%, respectively. 
When D 2 is compared with D~o both the ELISA and the IHA show a significant 
increase in percentage of positive results. The difference in GCFT sensitivities 
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Table 1 Sensitivities of three serological tests in patients with uncomplicated gonococcal infections attending an STD Clinic 
Sensitivity % 
U.,+;,....,+ ,.. ... ...,.,..,.., I=<T TSA THA GC'FT 
w 
00 
Table 2 Specificities of three serological tests in patients without current gonococcal infections attending an STD clinic 
Specificity % 
Patient groups 
ELISA IHA GCFT 
Dl D2 Dl D2 Dl D2 
1. FEMALES without current GC 
a. Reporting for STD check-up (n~28) 75 82* 71 71 96 96 
b. prostitutes (n~21) 52 38* 52 48 86 91 
2. MALES without current GC 
a. Reporting for STD check-up (n~72) 87 90 82 82 93 96 
b. With NGU (n~83) 84 83 75 76 90 94 
Table 2 (continued) 
P values when the ELISA, IHA and GCFT results are compared using McNemar's test 
Comparison P values in group 
la lb 2a 2b 
ELISA versus IHA Dl ns ns ns 0.05<p<0.10 
D2 ns ns ns ns 
GCFT versus ELISA Dl 0.05<p<OIO p<O.OS ns ns 
D2 ns p<O.Ol ns p<0.05 
GCFT versus IHA Dl p<O.OS p<0.05 p<O.OS p<O.Ol 
D2 p<O.OS p<O.Ol p<O.Ol p<O.Ol 
* On D2 for ELISA results: group la versus group lb p~0.003 (Fisher's test). 
is not significant. ELISA and IHA did not differ significantly in this total group 
of males. Both were significantly more sensitive than the GCFT. 
For males with 1-4 days of symptoms (n=79) the ELISA, IHA and GCFT 
sensitivities were 25%, 27% and 4%, respectively, on Db versus 34%, 39% 
and 10%, respectively, on D2• Comparison of the sensitivity on D2 with that on 
D 1 reveals a significant increase in the percentage of positive sera only in the 
IHA. Comparison of the three tests gives the same result as that in the total 
group of males. 
For males with 5-30 days of symptoms (n=34) the ELISA, IHA and GCFT 
sensitivities were 44%,53% and 23%, respectively, on D 1 versus 62%,77% 
and 23%, respectively, on D2. Comparison of the sensitivity on D2 with that on 
D 1 reveals a significant increase in percentage of positive sera in both the 
ELISA and the IHA. Only in this subgroup of males did ELISA and IHA 
sensitivities differ significantly on D2• The difference in sensitivity between 
ELISA and GCFT was significant only on D2 • IHA and GCFT differed 
significantly both on D 1 and on D2, as they did in the total group of males. 
Comparison of sera from males with 1-4 days with those from males with 
5-30 days of symptoms reveals higher sensitivities of all tests in the latter 
subgroup, the difference nearly always being significant. 
Patients withont gonorrhoea 
Table 2 shows the specificities of the three tests for patients without gonor-
rhoea. 
In females reporting for an STD check-up (n=28) the ELISA, IHA and 
GCFTspecificities were 75%,71% and 96%, respectively, onD 1, versus 82%, 
71% and 96%, respectively, on D2 • ELISA and IHA specificities did not differ 
significantly. ELISA and GCFT showed a near-significant difference in speci-
ficity only on D 1 (75% versus 96%). IHA and GCFT differed significantly 
both on D 1 and on D2 (71% versus 96%). 
The specificities of all tests were lowest for the prostitutes (n=21). The 
specificities of ELISA, IHA and GCFT were 52%, 52% and 86%, respecti-
vely, on Dh versus 38%, 48% and 91%, respectively, on D2. Again, ELISA 
and IHA did not differ significantly; both tests, however, were significantly less 
specific than the GCFT. 
In males reporting for an STD check-up (n=72) the specificities of the 
ELISA, IHA and GCFT were 87%, 82% and 93%, respectively, on Dh the 
corresponding specificities on D2 being 90%, 82% and 96%, respectively. 
Again, ELISA and IHA specificities did not differ significantly. The same 
applies to ELISA and GCFT. Comparison between GCFT and IHA, however, 
reveals a higher specificity of GCFT. Test specificity for males with NGU was 
slightly lower than that in the preceding group. ELISA, IHA and GCFT scored 
84%, 75% and 90%, respectively, on Dll versus 83%, 76% and 94%, res-
pectively, on D2 • In this group the difference between ELISA and IHA on D 1 
just escapes significance (84% versus 75%). Only on D2 did the GCFTshow a 
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Tabel 4 (continued) 
P values when test results (sensitivity) in groups with and without previous GC 
are compared using Fisher's test 
Comparison ELISA IHA GCFT 
group la versus lb D1 ns p=0.02 ns 
D2 ns ns ns 
group 2a versus 2b D1 ns p=0.006 p=0.07* 
D2 ns p=0.05 ns 
* in reversed direction: group 2b versus 2a. 
is recorded, only on D2 for females the increase is not significant. For gonor-
rhoea patients with a record of previous gonorrhoea it is remarkable that the 
percentage of positive sera in the GCFT is even smaller than that in the groups 
without previous gonorrhoea. 
Comparing the different groups of patients without gonorrhoea (table 5), we 
Table 5 The effect of previous gonococcal infection(s) on the specificities of three 
serological tests for detection of gonococcal antibodies 
Patient groups Specificity % 
ELISA IHA GCFT 
D1 D2 D1 D2 D1 D2 
I. FEMALES without current GC (n=49) 
a. with previous GC (n=28) 61 46 46 43 89 93 
b. without previous GC (n=21) 71 86 86 86 95 95 
2. MALES without current GC (n=155) 
a. with previous GC (n=43) 77 74 70 72 86 88 
b. without previous GC (n=112) 89 91 81 81 96 98 
Table 5 (continued) 
P values when test results (specificity) in groups with and without previous GC 
are compared using Fisher's test 
Comparison ELISA IHA GCFT 
group lb versus la D1 ns p=0.007 ns 
D2 p=0.007 p=0.003 ns 
group 2b versus 2a D1 p=0.07 ns p=0.07 
D2 p=0.02 ns p=0.02 
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find a higher specificity of all tests in the groups without a record of previous 
gonorrhoea. The three tests all show a (partly significant) difference in this 
respect. 
Other groups (table 6) 
The specificity of all three tests is high in the groups of blood donors 
(n=l19) and children (n=58). 
Table 6 Specificities of three serological tests for detection of gonococcal antibodies in 
blood donors and children 
Groups 
Blood donors (n=119) 
Children aged 10-12 years (n=58) 
ELISA 
100 
100 
Specificity % 
IHA 
94 
100 
Supplemental information obtained by combining the tests 
GCFT 
99 
100 
Tables 7 and 8 list the results of the tests, separately and in combination. 
Table 7 shows the sensitivity in females with uncomplicated gonorrhoea 
(n=104). The highest sensitivity is of course attained when the results of all 
three tests are combined: 68% positive sera on D 1 and 70% on D 2 • The 
percentage of positive sera with the combined ELISA and/or IHA results 
virtually equals that with the three tests combined: 67% on D 1 and 69% on D 2 • 
Table 7 Results obtained by using one or more of three serological tests for detection of 
gonococcal antibodies in 104 females with uncomplicated urogenital/rectal 
gonorrhoea 
Test or combination of tests 
ELISA 
IHA 
GCFT 
ELISA and/ or GCFT 
IHA and/ or GCFT 
ELISA and/ or IHA 
ELISA and/ or IHA and/ or GCFT 
D1 
45 
58 
21 
52 
61 
67 
68 
Sensitivity % 
D2 
53 
54 
22 
56 
59 
69 
70 
43 
Table 8 shows the sensitivity in males with nncomplicated gonorrhoea 
(n= 129). The highest sensitivity is of course again attained when the results of 
the three tests are combined: 46% positive sera on 0 1 and 60% on 0 2• As in 
the females, the percentage of positive sera with the combined ELISA and/or 
IHA results virtually equals the sensitivity attained with the combination of the 
three tests: 44% on 0 1 and 59% on 0 2 . 
Specificity decreases accordingly when the test results are combined. 
Table 8 Results obtained by using one or more of three serological tests for detection of 
gonococcal antibodies in 129 males with uncomplicated urogenital/rectal go-
norrhoea 
Sensitivity % 
Test or combination of tests D1 D2 
ELISA 32 41 
IHA 36 50 
GCFT 10 14 
ELISA and/ or GCFT 33 45 
IHA and/or GCFT 38 52 
ELISA and/ or IHA 44 59 
ELISA and/ or IHA and/ or GCFT 46 60 
Degree of agreement between the tests 
The agreement between the tests is measured with the aid of the coefficient 
kappa. Table 9 presents tbe agreement between the results of the ELISA, IHA 
and GCFT; 466 examinations were performed in 233 patients with uncompli-
cated gonorrhoea (two samples from each patient). 
By way of example we present a comparison between ELISA and IHA in 
detail. Both tests! were performed N =466 times. The number of agreeing 
results observed was: no = 146 + 191 = 337. The number of agreeing results 
expected in the case of statistical independence is: n, = 95 + 140 = 235. The 
expected number is calculated exactly as in a chi-square test. When the two 
tests agree only by chance, the expected and the observed numbers are about 
equal. In the case under consideration the observed number of agreeing results 
exceeds the expected number: no - n, = 337 - 235 = 102. The maximum 
possible difference is: N- n, = 466 - 235 = 231 (when all results of both tests 
are the same). The ratio (no - n,)/(N - n,) is known as the coefficient of 
agreement kappa. In this case kappa = 102/231 = 0.44. 
For the agreement between ELISA and GCFT kappa = 0.26. Nearly the 
same result is obtained when IHA and GCFT are compared, namely kappa = 
0.20. 
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Table 9 Agreement between three serological tests for detection of gonococcal antibo-
dies in 233 patients with uncomplicated gonorrhoea on the date of first exami-
nadon (Dl) and 11-22 days later (D2) 
+ 
+ 146 (95) 
ELISA - 79 
+ 
+ 59 (32) 
ELISA - 17 
+ 
+ 60 (37) 
IHA - 16 
+ = positive, - = negative. 
IRA 
GCFT 
GCFT 
50 
191 (140) 
137 
253 (226) 
165 
225 (202) 
kappa=0.44 
SE=0.04 
kappa=0.26 
SE=0.04 
kappa=0.20 
SE=0.03 
The number which can be expected under statistical independence is given in brackets. 
Discussion 
Many serological tests for detection of antibodies to gonorrhoea have been 
developed. However, it is difficult to compare the various results because the 
tests were performed under different conditions. The culture technique, the 
sites from which the cultures were taken and the selection of patient popula-
tions differ widely in the different studies. Few studies have compared two or 
more serological tests in the same patient population6' 18-20 • 
Danielsson et al 20 compared a GCFT and an immuno-electrophoresis test 
(IE) in the same, well-defined patient groups. The GCFT scored 20-25% in 
males and 30-40% in females with uncomplicated gonorrhoea. The sensitivity 
of the IE was 24% in patients (male and female) with uncomplicated gonor-
rhoea. 
Reimann et aL 6 compared an IHA test using a mixture of pili from two 
Danish gonococcal strains as antigen with the GCFT (routine test in Denmark 
until1979). The sensitivity of the IHA test was 70% for females and 59% for 
males. The GCFT sensitivity was 9% in both groups. 
We performed a comparative study of three tests: an ELISA and IHA, using 
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two different gonococcal pili as antigen, and a GCFT using whole gonococcal 
cells as antigen. 
We found the highest ELISA and IHA sensitivities in patients with com-
plicated gonococcal infections and oropharyngeal gonorrhoea, in asymptoma-
tically infected females, and in males with 5-30 days of symptoms of uncompli-
cated gonorrhoea. The sensitivity of the GCFT was very low in the uncompli-
cated infections. In uncomplicated gonorrhoea the highest sensitivity (27%) 
was attained on D2 (11-22 days after the first examination) for females with 
symptomatic infections. The sensitivities were much higher in complicated and 
oropharyngeal gonorrhoea, although they were still lower than those of 
ELISA and IHA. In oropharyngeal gonorrhoea the sensitivity of the ELISA 
was significantly higher than that of the GCFT, and near-significantly higher 
than that of the IHA. Only for symptomatically infected females and males 
with 5-30 days of symptoms of uncomplicated gonorrhoea did ELISA and 
IHA differ significantly in sensitivity (IHA being superior). The ELISA would 
generally seem to be slightly more specific than the IHA, but its sensitivity 
seemed to be slightly lower except in oropharyngeal gonorrhoea, where it was 
superior to IHA. 
Using the coefficient of agreement kappa, we found a higher degree of 
agreement between ELISA and IHA (kappa = 0.44) than between each of 
these tests and the GCFT (kappa = 0.26 and 0.20). The ELISA and IHA 
systems have virtually the same sensitivity, but the coefficient of agreement in 
our study is nevertheless lower than might be expected. The unexpectedly low 
agreement may be due to different antigenic determinants on the two pilus 
antigens. But this can only partly explain the relatively low agreement. Ano-
ther but improbable possibility is that different components of the pili are 
available as antigen in each system. 
Reimann et al. (1982)21 recently reported that antigenic heterogeneity of 
gonococcal pili exists if human sera are used in the test system (chapter 7). It 
turned out that pili of strain 6650 (Rotterdam) had a broader antigenicity in 
the IHA than the pili of Buchanan's strain 2686. In females with uncomplica-
ted gonorrhoea (same sera as in this study) Reimann et al. 21 attained sensitivi-
ties of 66% and 71% on D 1 and D2, respectively. Oranje et al. (chapter 8), 
using an ELISA performed with pili of strain 6650 in the same patient 
population, attained virtually the same results: 69% on D 1 and 67% on D2 . 
The two pilus tests are far more sensitive than the GCFT, but the specificity 
of the latter is higher in high-risk groups. The low specificity of the pilus tests in 
these groups is partly due to the large proportion of patients with a history of 
previous gonococcal infections. Holmes et al.22, Reimann et al. 11 and the 
present authors found that antibodies to gonococcal pili are mostly of the IgG 
class and can therefore persist very long (sometimes for years). Not infre-
quently, some patients attending STD clinics may, without being aware of it, 
cure their gonococcal infection with antibiotics they already have in stock. 
Culture will then be negative but the serological test result may be positive. 
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The persistence of antibodies to gonococcal pili and (partly unsupervised) use 
of antibiotics also explain the low specificity of the tests in prostitutes. More-
over, the sensitivity of the gonococcal cultures is not 100% either. For 
example, the ELISA as applied in the prostitutes revealed three patients from 
whom no gonococci could be cultured but who showed a marked increase in 
absorbance within two weeks- indicating a current or a very recent infection. 
For proper evaluation of a serological test for detection of gonorrhoea, there-
fore, insight into the incidence of false negative gonococcal culture results is of 
great importance. 
It is oflittle use to eombine one of the two pilus tests with the GCFT. When 
the ELISA and IHA results are combined, a sensitivity is attained which nearly 
equals the combined sensitivity of the three tests. The value of the GCFT as 
performed in this study, is exceedingly limited. 
The findings warrant the conclusion that gonococcal pili constitute an ex-
cellent antigen, which may be improved by including antigenically different 
pilus antigens in the antigen preparation used, or by replacing the antigen with 
a more broad-spectred pilus antigen. 
A positive serological reaction should always be confirmed with positive 
cultures or positive clinical symptoms (complicated gonorrhoea) before the 
diagnosis gonorrhoea is put forward and treatment started. The pilus tests 
with their relatively high sensitivities may be suitable for case-detecting and 
screening. 
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CHAPTER 7 
Demonstration of Antigenic Heterogeneity of 
Neisseria Gonorrhoeae Pilus antigens using 
human sera in the test system 
Karin Reimann*, Arnold P. Oranje** and Marc F. Michel* 
Department of Clinical Microbiology and Antimicrobial Therapy* and 
Department of Dermatology and Venereology**, Erasmus University Rotterdam. 
Summary 
Antigenic heterogeneity of gonococcal pili using human sera in the test 
system was demonstrated by means of indirect haemagglutination inhibition. 
The reactivities of sera from 104 females with current gonococcal infection 
were compared by the IHA test using different pilus preparations as antigens. 
Pili were purified from 22 strains infecting patients who met the following 
three requirements: 1) no history of previous gonococcal infection(s), 2) an 
infection that has lasted a week or more, 3) a seronegative result when tested 
by the IHA test using pili from Buchanan's strain 2686 as antigen. Each 
patient's serum was tested against pili produced by the gonococcal strain 
infecting this particular patient. A seropositive reaction obtained by using pilus 
antigen from the strain infecting the seronegative (strain 2686) patient indi-
cates an antigenically heterogeneous pilus preparation. Two such strains, 
antigenically different from one another and from strain 2686, were found 
among 22 pilus preparations studied. 
Introduction 
Several serological tests using gonococcal pili as antigen have been descri-
bedl-4. The results obtained for human sera have been uniform and indepen-
dent both of the test system and of the strain(s) used for pilus preparation5 
This suggests that man recognizes very homologous determinants on gonococ-
cal pili as opposed to rabbits6 • However, none of the serological tests described 
has a sensitivity higher than 89% (asymptomatically infected females) 1• The 
1. Published in Acta Path. Microbial. Immunol. Scand. Sect. C. 1982, 90: 47-52. 
Reprint with permission of the publisher. 
2. Present address of first author: Karin Reimann, Neisseria Department, Statens 
seruminstitut, 80 Amager Boulevard, DK-2300 Copenhagen S. Denmark. 
3. This study was supported by a grant from ELI LILLY. 
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missing percentages could be due to: 1) an infection too brief to stimulate 
increased antibody levels to pili, 2) a lack of ability in the patient to develop 
pilus antibodies or 3) a lack of antigenic determinants in the pilus antigen used 
to recognize the pilus antibodies generated by the infecting gonococcal strain. 
This last possibility was investigated by testing individual human sera by means 
of the IHA test using pilus antigen prepared from the gonococcal strain causing 
the infection. 
Our hypothesis was that once antigenic heterogeneity of gonococcal pili 
was proven in human sera, the sensitivity of tests to detect antibody to pili in 
patients with gonorrhoea may be increased by including more than one antige-
nic type of pili in the antigen preparations. 
Materials and Methods 
IHA test using gonococcal pili as antigen 
The test was performed as described earlier' with a few important and 
timesaving modifications: a) prior to use the pilus antigen was sonicated for 
one minute at ooc (8 micron using an MSE ultrasonic disintegrator, probe 3,3 
mm), b) none of the sera was inactivated, nor was any absorbed with formalin-
treated sheep red blood cells (SRBC), c) the agglutination patterns were read 
after one hauL The titre of a given specimen was read as the reciprocal value of 
the highest serum dilution giving a + reaction. Titres >-. 40 were considered 
positive but only if the reaction in the first well (serum dilution 1/20) was read 
as + + or more. 
Haemagglutination inhibition experiments 
These studies were performed as described previously7 
Patients 
Sera and correspondent gonococcal strains were collected from 170 female 
and 195 male patients with current gonococcal infection admitted to the STD 
clinic at Dijkzigt Hospital, Rotterdam, in the period September 1977-July 
1978. All sera were studied by the IHA test for gonococcal pilus antibodies, 
using pili from Buchanan's strain 2686 as antigen. We selected sera and 
gonococcal strains from these patients who met the following three require-
ments: 1) no history of past gonococcal infection(s), 2) an infection that had 
lasted a week or more before sampling, 3) a seronegative result when tested by 
the IHA using pili 2686 as antigen. A total of 28 patients fulfilled these three 
conditions. Pilus antigen was purified from 22 of the strains causing gonococcal 
infection according to the method of Hermodson et al.8 No pili could be 
prepared from the remaining six strains for various reasons. 
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Results 
Selection of Study Group 
Table 1 summarizes the eleven female and the eleven male patients fulfilling 
the criteria given in Materials and Methods. Each patient's serum was tested 
against the specific antigenic type of pili produced by the gonococcal strain 
infecting this particular patient. Our hypothesis was that a seropositive 
reaction obtained with a patient's own pili in an otherwise seronegative patient 
would indicate an immunological disparity between the two pilus antigens. By 
only including patients without a previous gonococcal infection we could be 
Table 1 IHA test performed on sera from 22 patients with current gonococcal infection 
without previous GC using pili from the infecting strairis as antigens 
Patient sera IHA titre obtained by using pilus antigen: 
Sex No. No. of days with infection from infecting strain 6650* 30605** 
M' 1 7- 30 *.!!:.* .• 
M 2 7- 30 
M 3 7-30 
M 4 unknown 
M 5 7- 30 ~0 80 
M 6 ?30 
M 7 ;:::30 
M 8 7- 30 
M 9 unknown 
M 10 7- 30 
M 11 ~30 
pA 12 7- 30 
F 13 unknown 
F 14 7-30 
F 15 unknown 
F 16 7- 30 
F 17 ~30 80 80 160 
F 18 ;;:::30 160 80 160 
F 19 unknown 
F 20 ~30 
F 21 7- 30 80 80 80 
F 22 7-30 320 320 640 
* 6650 is the strain causing gonococcal infection in patient F22. 
** 30605 is the strain causing gonococcal infection in patient MS. 
*** - = IHA titre is negative (,;20). 
• . =not done . 
A M = male, F = female. 
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certain that the pilus antibodies found were really induced by the strain causing 
the present infection. Table 1 shows five patients- M5, F17, F18, F21 and F22 
-who demonstrated a positive antibody response when pili made from the 
infecting strain were used as antigen. Strain 6650, cultured from the rectum of 
patient F22, was by far the best pilus antigen producer and was thus selected 
for further investigations. Sera from patients MS, F17, F18 and F21 were 
re-tested, this time using pili 6650 as antigen; all sera except that from patient 
MS were positive. This suggested that pili from strain 30605 infecting patient 
MS possessed yet a third set of antigenic determinants. Again the sera from the 
interesting patients- F17, Fl8, F21 and F22- were tried by the IHA test using 
pili produced by strain 30605 as antigen. All sera gave a positive antibody 
response, which meant that no more anti genically different pili could be found 
in this material. Pili from strain 30605 were not investigated further in this 
study; the pilus production of this strain was only half the production of strain 
6650. It should be noticed that the heterologous titres and the homologous 
titres are of the same magnitude when the same human serum was being tested, 
thus indicating that in case of common antigenic determinants the shared 
cross-reactivity was 100%. 
Haemagglutination Inhibition Studies 
Tables 2 and 3 show two haemagglutination inhibition assays reaffirming the 
antigenic difference between pili from strain 2686 and strain 6650 when using 
human sera in the test system. Table 2 summarizes an experiment where SRBC 
(sheep red blood cells), sensitized with pili 2686, were used as antigen; the 
inhibitors were pili 2686 and pili 6650. The sera studied were "pool serum" (a 
pool of eight positive sera) giving a positive reaction when tested against both 
pili 2686 and pili 6650, and "serum A" giving a positive reaction only when 
tested against pili 2686. The reaction in the "pool serum" was inhibited both 
by addition of pili 2686 and pili 6650 one hour prior to addition of the 
sensitized blood. The reaction in "serum A" was inhibited only by addition of 
pili 2686; no inhibition at all could be detected when pili 6650 up to a 
concentration of 0.4 [!g/ml were added. 
Table 3 shows a similar experiment. The antigen in this assay was SRBC 
sensitized with pili 6650, the inhibitors were the same as in the former experi-
ment and the sera were "pool serum" and "serum B", the latter being positive 
only when pili 6650 were used as antigen. The reactions in the "pool serum" 
were inhibited by both pilus preparations, but the reaction in "serum B" was 
inhibited only when pili 6650 were added and not by addition of pili 2686. 
Comparison of results obtained by using the two heterogeneous pilus 
antigens in the IHA test 
In order to establish whether the sensitivity of the IHA test could be 
improved, we tested a group of females with current uncomplicated urogeni-
tal/rectal gonorrhoea (56 with asymptomatic and 48 with symptomatic infec-
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Table 2 IHA test using pili 2686 (0.5 f!glm/) as antigen and using both pili2686 and pili 6650 as inhibitors 
IHA titre obtained by testing IHA titre obtained by testing 
inhibitor pili 2686 pool serum* serum A** inhibitor pili 6650 pool serum* serum A** 
f!g/ml f!g/ml 
0.0 160 160 0.0 160 160 
0.025 160 160 0.025 160 160 
0.05 160 160 0.05 160 160 
0.1 80 80 0.1 80 160 
0.2 40 40 0.2 40 160 
0.4 - *** - 0.4 - 160 
* 
** 
pool serum: giving a positive antibody response when tested by IHA using both pili 2686 and pili 6650 as antigens. 
*** 
serum A: giving a positive antibody response when tested by IHA using pili 2686 as antigen but a negative result if pili 6650 were 
used as antigen. 
IHA titre is negative ( ,;20). 
Table 3 IHA test using pili 6650 (0.5 f!g/ml) as antigen and using both pili 2686 and pili 6650 as inhibitors 
IHA titre obtained by testing IHA titre obtained by testing 
inhibitor pili 2686 pool serum* serum B** inhibitor pili 6650 pool serum* serum B** 
f!g/ml I' g/ml 
0.0 320 80 0.0 320 80 
0.025 160 80 0.025 160 80 
0.05 80 80 0.05 80 40 
0.1 40 80 0.1 40 
0.2 *** 80 0.2 
0.4 - 80 0.4 
* 
** 
pool serum: giving a positive antibody response when tested by IHA using both pili 2686 and pili 6650 as antigens. 
*** 
serum B: giving a positive antibody response when tested by IHA using pili 6650 as antigen but a negative result if pili 2686 were 
used as antigen. 
IHA titre is negative (,;20). 
V; 
a-, 
Table 4 Sera from 104 females with current gonococcal infection tested by the IRA test usingpili2686, pili 6650andpilus pool (2686 + 
6650) as antigens 
Pilus antigen 
2686' 
6650* 
pool (2686 + 6650)*' 
* concentration: 0.5 !lglml. 
** concentration: 1.0 !Ag/ml. 
56 females with 
asymptomatic GC 
D, D, 
63 55 
73 75 
79 77 
Sensitivity % when testing patient group 
48 females with 
symptomatic GC Total 
D, Dz D, D, 
52 52 58 54 
58 67 66 71 
65 71 72 74 
Table 5 P-values (McNemar's test) for differences in sensitivity using pili 2686, pili 6650 and pilus pool (2686 + 6650) as antigens 
(based on the results shown in table 4) 
Comparison 
6650 versus 2686 
pool (2686+6650) versus 2686 
pool (2686+6650) versus 6650 
56 females with 
asymptomatic GC 
D, Dz 
ns p<O.Ol 
ns p<O.Ol 
ns ns 
48 females with 
symptomatic GC Total 
D, D, D, D, 
ns 0.05<p<O.!O 0.05<p<O.!O p<O.Ol 
0.05<p<0.10 p<O.Ol p<O.Ol p<O.Ol 
ns ns ns ns 
tion) using pili 2686, pili 6650 and a pool of pili (2686 + 6650) as antigen 
(Tables 4 and 5). Blood samples were drawn from all patients on D 1: date of 
first examination and on D2: 11-22 days after Dl. The results obtained by 
using pili 2686 as antigen were compared with the results found by using pili 
6650 as antigen (McNemar's test9). Likewise, we compared the results by 
using pili 6650 as antigen with the results obtained when a pool of the two pilus 
preparations 2686 + 6650 was used as antigen. No significant differences were 
found in this last comparison, but when the sensitivities found with pilus 
antigen 2686 were compared with those attained with pilus antigen 6650 and 
pilus pool (2686 + 6650), a significant improvement was measured using the 
latter two pilus antigens. 
In order to evaluate a possible difference in specificity of the IHA test using 
the different pilus preparations as antigens, we tested sera from 119 blood 
donors as well as from 58 healthy children aged 10-12 years. The results shown 
in Table 6 indicate no significant decrease in specificity when using pili 6650 or 
pilus pool (2686 + 6650) as antigen instead of pili 2686. 
Table 6 Sera from 119 blood donors and 58 children aged 10-12 years tested by the 
IHA test using pili 2686, pili 6650 and pilus pool (2686 + 6650) as antigens 
Pilus antigen 
2686* 
6650* 
pool (2686 + 6650)** 
* concentration: 0.5 ~-tg/ml. 
** concentration: 1.0 (lg/ml. 
Discussion 
Specificity % when testing 
119 blood donors 58 children aged 10-12 years 
94 
92 
92 
100 
100 
100 
The properties of gonococcal pili and their antigenic relationship have been 
reviewed by Buchanan10 A high degree of heterogeneity has been reported 
when guinea-pig serum or rabbit serum was used in the test systemsll-15 
Novotny and Cownley15 found no general low-level serological cross-reactivity 
between pili from 50 gonococcal strains if sera from rabbits or guinea-pigs 
immunized with whole cells were used in their test system, immune electron 
microscopy. Buchanan10 reported that shared antigens accounted for 2.5% or 
less when the antigenic structure of pili from four different gonococcal strains 
was investigated using rabbit antibodies to purified pili in the RIA system. 
Brinton et alll also used rabbit antisera to gonococcal pili. Depending upon 
the test system used, they found a shared cross-reactivity of 5-15% between 46 
57 
gonococcal pilus serotypes, i.e. rabbit antiserum heterologous titres were 
approximately 5-15% of the homologous titres. 
On the other hand serological tests using gonococcal pili as antigen'·' have, 
when performed on sera from patients, exhibited sensitivities far above what 
could be expected, had human sera recognized the same antigenic deter-
minants as rabbit sera. This apparent difference in cross-reactivity prompted 
the study by Lind and Reimann' in which rabbit antisera to pili and sera from 
seropositive patients were used in IHA inhibition experiments. Pili from four 
strains were tested; only two strains possessed common antigens detectable by 
means of rabbit antisera (weak cross-reactivity), but all four cross-reacted 
100% when human sera were used in the system. Brinton et al. 11 have reported 
nearly 100% cross-reactivity among 50 pilus preparations from arbitrarily 
chosen strains when sera from naturally diseased humans were used in the test 
system. 
In order to establish whether antigenic heterogeneity existed or not, we 
could use only sera and strains from patients without a history of previous 
gonorrhoea, i.e. we only wanted to demonstrate antibodies stimulated by pili 
from the currently infecting strain. Sera and strains from 28 patients were 
therefore selected according to the criteria described in Materials and Me-
thods, and pilus antigen was purified from 22 of these strains. If a patient was 
seronegative also when tested against pilus antigen from the infecting strain, 
we concluded that the infection time before sampling was too short for for-
mation of a detectable level of antibodies or that the patient lacked the ability 
to generate pilus antibodies. Five of the 22 patient sera gave a positive 
antibody response when tested against pili produced by the infecting strain. 
Two of these strains possessed pili whose antigenic determinants differed from 
one another and from those of pili 2686. 
Strain 6650 (being by far the best pilus antigen producer) was used in a study 
where we compared the sensitivities obtained by using pili 2686 alone, pili 
6650 alone or a pool of pili (2686 + 6650) as antigens in the IHA test. We 
found a significant increase in sensitivity of the IHA test if pili 6650 alone or a 
pool of the two anti genically different pilus preparations (2686 + 6650) were 
used as antigens instead of using pili 2686 only. No significant difference was 
found when we compared the results obtained with the pool antigen with those 
found with pili 6650 alone. 
One explanation of the increased sensitivity could be that pili of strain 6650 
had a broader spectrum of antigenic determinants than pili of strain 2686. 
There is also a possibility that antigenic types of pili produced by gonococci 
differ in different geographic areas, and this may explain why the IHA test 
using pili from strain 6650 (isolated from a patient from Rotterdam) as 
antigen, resulted in a significantly higher sensitivity for patients visiting an 
STD clinic in Rotterdam than when pili of strain 2686 (isolated years ago in the 
USA) were used. 
The heterogeneity of gonococcal pili when human sera were used in the test 
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system should be borne in mind when selecting suitable antigens for serological 
tests or for future vaccines. 
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CHAPTER 8 
Enzyme-linked immunosorbent assay (ELISA) 
for detection of gonococcal antibodies using two 
antigenically different gonococcal pili as antigen. 
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Summary 
Antibodies to pilus antigens of two gonococcal strains (6650 and 1443) 
isolated in Rotterdam, were detected in paired sera from females with and 
without gonorrhoea attending an STD clinic. 
The sensitivity of the ELISA using gonococcal pili 6650 as antigen (ELISA 
6650) was significantly higher than that attained using gonococcal pili 1443 as 
antigen (ELISA 1443). The specificity of the two tests hardly differed. On D1 
the sensitivity in females with uncomplicated gonorrhoea was 69% in the 
ELISA 6650 and 45% in the ELISA 1443; the corresponding values in 
asymptomatically infected females were 75% and 57%, respectively. 
The agreement (both in positive and in negative results) between the two 
tests was less than might be expected (kappa=0.41). 
Introduction 
Antigenic heterogeneity of gonococcal pili to gonococcal antibodies in 
human sera was first demonstrated by Reimann et al. (chapter 7)1 using an 
IHA. Three antigenically different pilus preparations were demonstrated. 
The sensitivity of the IHA using one of these pilus preparations as antigen 
(6650) was significantly higher than that attained by using the antigenically 
different pili 2686 as antigen. The sensitivity of the enzyme-linked immuno-
sorbent assay (ELISA) using gonococcal pili 1443 as antigen virtually equalled 
that of the IHA using gonococcal pili 2686 as antigen (chapter 6)2 
The aim of this investigation was to establish whether the use of gonococcal 
pili 6650 as antigen in the ELISA would also increase the sensitivity as 
compared with that attained with pili 1443 as antigen. 
Complete paper accepted for publication in the Brit. J. Vener. Dis. 
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Material and Methods 
We studied sera from 104 females with uncomplicated gonorrhoea and 28 
females who requested a check-up for STD. Sera from blood donors (n=ll9) 
and from healthy children aged 10-12 (n=58) were used as control sera. All 
sera used in this study belong to the serum material previously studied in detail. 
(chapter 5, page 20-21) 
Gonococcal strains and preparations of pilus antigen 
The gonococcal strains used were 1443 and 6650, both isolated in Rot-
terdam. Pili 1443 were purified as described by Robertson et al. 3 Pili 6650 
were purified according to Hermodson et a!. 4 In the former case the gonococci 
were homogenized and, after differential centrifugation, purified over a 
caesium chloride gradient. In the latter case gonococci were pre-processed in 
the same way but purified by precipitation with ammonium sulphate. On the 
basis of electron-microscopic examinations the pilus preparations looked 
equally pure. 
ELISA 
The ELISA procedure was carried out as previously described (chapter 4). 
In the same way as in the ELISA using gonococcal pili 1443 as antigen (ELISA 
1443), the breakpoint in the ELISA with pili 6650 as antigen (ELISA 6650) 
was determined as A?o0.85. The breakpoint was chosen in such a way that all 
sera from 58 healthy children aged 10-12 years were completely negative. 
Results with absorbance values between 0.75 and 0.85 were regarded as 
dubious, and those with absorbance values between 0.85 and 0.95 as weakly 
positive in the ELISA 6650. In both assays the coefficient of variation within 
the test (plate-to-plate) and between tests (day-to-day) was less than 15%; 
only for unmistakably negative sera was this coefficient higher. 
Statistical analysis (see chapter 6, page 36)'· '· '· s 
Resnlts 
Females with uncomplicated gonorrhoea 
Table 1 shows the percentage of positive sera in both ELISA tests for 
females with uncomplicated gonorrhoea (n=l04). At the date of the first 
examination the ELISA 6650 was positive in 69% of the sera, and 11-22 days 
later this assay was positive in 67% of the sera. 
The 104 patients were divided into females with asymptomatic infections 
(n=56) and females with symptomatic infections (n=48). The sensitivity of 
the ELISA 6650 was higher in the former (D1: 75%, D2: 70%) than in the 
latter group (D 1: 63%, D2: 65% ). This difference is not significant. In neither 
group did the testing of a second serum sample give any advantage in terms of 
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Table 1 Comparison of the sensitivities attained by using pili 6650 and pili 1443 as antigen in the ELISA. Sera from 104 females with 
uncomplicated gonorrhoea were tested 
Sensitivity of the ELISA % 
56 females with 48 females with total group of 104 females 
asymptomatic GC symptomatic GC with uncomplicated GC 
D1 D2 D1 D2 D1 D2 
Pili 6650 75 70 63 65 69 67 
Pili 1443 57 61 31 44 45 53 
McNemar's test p < 0.05 ns p < 0.01 p < 0.01 p < 0.01 p < 0.01 
"' -'" 
Table 2 Comparison of the specificities attained by using pili 6650 and pili 1443 as antigen in the ELISA. Sera from females without 
gonorrhoea, blood donors and children were tested 
Specificity of the ELISA % 
Pili 6650 
Pili 1443 
McNemar's test 
28 females without gonorrhoea 
who requested an STD check-up 
D1 D2 
71 73"' 
75 82 
ns ns 
* only 26 serum samples tested. 
119 blood donors 
92 
100 
p < 0,01 
58 children aged 10-12 
100 
100 
ns 
increased sensitivity. Generally, the sensitivity of the ELISA 6650 exceeded 
that of ELISA 1443. This difference in sensitivity was significant except on D2 
in the group of females with asymptomatic infections. 
Specificity 
Table 2 shows the specificity of ELISA 6650 and ELISA 1443 for females 
without gonorrhoea who requested a check-up for STD (n=28), for blood 
donors (n=119) and for healthy children aged 10-12 (n=58.) There was 
hardly any difference in specificity when using the two antigens. For the blood 
donors the ELISA 1443 was positive in none of the sera and dubious in 2%, 
the corresponding figures for the ELISA 6650 being 8% and 5%, respectively. 
For the children the ELISA 1443 was dubious in 7% of the sera, while the 
ELISA 6650 was dubious in none. 
Degree of agreement between the tests 
The agreement between the tests was measured using the coefficient kappa. 
Table 3 shows the agreement or dis-agreement between the tests in 208 
determinations (N) made in 104 female patients with uncomplicated gonor-
rhoea. Agreement was observed in 147 tests (no)· The number of agreements 
expected under statistical independence is 105 (n,). The ratio (no-n,)/(N-n,) is 
known as the coefficient of agreement kappa. For agreement between the two 
tests, kappa =(147-105)/(208-105) = 42/103 =0.41. 
Table 3 Agreement between assays using different gonococcal pili (6650 or 1443) as 
antigen in testing sera from 104 females with uncomplicated gonorrhoea at date 
of first examination (Dl) and 11-22 days later (D2) 
Pilus 1443 assay 
+ = positive. 
- = negative. 
+ 
+ 93 (72) 
49 
Pilus 665 0 assay 
12 
54 (33) 
kappa = 0.41 
SE = 0.06 
Number to be expected under statistical independence is given in brackets. 
Discussion 
Serological tests using gonococcal pili as antigen for detection of gonococcal 
antibodies have been described in several publications 9•13 . The high sensitivity 
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attained by Buchanan et al. 10 using a RIA, 86% in females with uncomplicated 
gonorrhoea, was never attained in any of the other studies9' It, 12, except that of 
Oates et al. 13 for asymptomatically infected females. 
Differences in sensitivity attained in the various studies could be due to 
differences in patient material, to the test system used, but also to the different 
gonococcal pili used as antigen. Reimann et al. (chapter 7) 1 attained signifi-
cantly different sensitivities when using pili from strains 6650 and 2686 as 
antigens in the IHA test performed on the same sera as were used in this study. 
This study was undertaken to establish whether the use of pili 6650 as 
antigen would increase the sensitivity of the ELISA as compared with that 
attained using pili 1443 as antigen. This was indeed the case (69% with pili 
6650 and 45% with pili 1443 on 0 1). The specificities hardly differed. 
Using the coefficient of agreement kappa, a lower degree of agreement was 
found between the two versions (kappa= 0.41) than might be expected. In fact 
this agreement was even less than the kappa (0.44) between the ELISA 1443 
and the IHA using gonococcal pili 2686 as antigen (chapter 6)2 This is 
probably entirely due to the heterogeneity of the pilus preparations. 
It would be interesting to use a pool of these two or more pilus preparations 
as antigen in the ELISA. Combination of pili 6650 with pili 2686 in the IHA 
did not lead to the desired improvement (chapter 7) 1• The heterogeneity of 
gonococcal pili when using human sera in the test system is emphasized once 
more and should be borne in mind when choosing antigens for serological tests 
or for vaccination. 
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CHAPTER 9 
Antibodies to gonococcal pili in asymptomatic 
females 
The diagnostic value of testing serum samples by ELISA in 
females without complaints attending an STD clinic in Rotterdam 
Arnold P. Oranje*, Carmen O.A.-Iserief*, Annet de Roo**, Ernst Stolz* and Marc F. 
Michel** 
* Department of Dermatology and Venereology, Erasmus University, Rotterdam. 
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Summary 
The diagnostic efficacy of the ELISA using gonococcal pili 6650 as antigen 
was studied in females without complaints attending an STD clinic for exami-
nation and, if necessary, treatment. The total number of females studied was 
182, and gonorrhoea was diagnosed in 52 (29% ). 
The value of the ELISA was calculated on the basis of four arbitrary 
breakpoints in the test. The best predictive value for a positive result (PV( + )) 
was obtained at breakpoint A?-1.15; the best predictive value for a negative 
result was obtained at breakpoint A:;,0.85. 
It is proposed that the ELISA be used as follows. The result is positive at 
A?o1.15, negative at A <0.85, the PV( +)then being 0.52 and the PV(-) being 
0.85. Whenever sera give a result between A=0.85 and A=1.15, the test 
should be repeated. 
In this version, the ELISA is of some assistance in the diagnosis of gonor-
rhoea in this group of patients. 
Introduction 
Females with asymptomatic gonorrhoea constitute a source from which 
fresh infections can readily arise. Serological tests to detect gonorrhoea which 
use gonococcal pili as antigen, prove to score high in females with asymptoma-
tic gonococcal infections. 1· 5 
Our previous studies showed that the ELISA t:sing gonococcal pili of strain 
6650 as antigen attains a sensitivity of 75% in females with asymptomatic 
urogenital/rectal gonorrhoea (chapter 8).4 
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This paper discusses the diagnostic efficacy of the ELISA using gonococcal 
pili 6650 as antigen if several absorbance breakpoints in the test are consider-
ed. Sera from females without complaints who attended the STD clinic of the 
Rotterdam University Hospital Dijkzigt for examination and, if necessary, 
treatment were tested with the ELISA so interpreted. 
Material and Methods 
Patients 
We collected sera from 182 females without complaints who attended the 
STD clinic of tbe Rotterdam University Hospital Dijkzigt between 1st January 
and 15th December 1981. Professional female prostitutes were excluded. At 
each visit material was obtained from the cervix, urethra, rectum and oro-
pharynx and tested for gonococci by means of a culture. The specimens were 
cultured on selective Thayer-Martin' medium, and suspect oxidase-positive 
colonies were identified as gonococci by Gram staining and sugar fermentation 
tests. When all cultures were negative, the examination was repeated after one 
week if possible. When all cultures were again negative, the females were 
considered not to suffer from gonorrhoea. There were no patients with a 
positive Gram stain and negative cultures. In addition, all patients were 
routinely tested for the presence of other STD (Stolz)7 
Gonococcal strain and preparation of pilus antigen 
Pili of strain 6650 (Rotterdam) were used to prepare the antigen. They were 
purified according to Hermodson et al. 8 
ELISA 
The ELISA procedure was carried out as already described (chapters 4 and 
8).'·4 
Results 
Prevalence of gonorrhoea 
Of the 182 females, 52 were suffering from asymptomatic urogenital/rectal 
gonorrhoea (table 1); one had oropharyngeal gonorrhoea as well. In addition, 
26 females reporting as gonorrhoea contacts had gonorrhoea-negative cul-
tures. These patients were as a rule treated on the basis of the history. The 
remaining 104 patients neither suffered from gonorrhoea nor reported as 
gonorrhoea contact. The prevalence of gonorrhoea was therefore 52/ 
182=29%. 
The patients were divided in addition into those with and those without a 
history of gonorrhoea (table 1). A history of gonorrhoea existed in 36 of the 
182 patients, i.e. 20%. The previous gonococcal infection(s) dated back from a 
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Table 1 Classification by diagnosis of 182 asymptomatic females attending an STD 
clinic 
Patient groups Number of patients 
Asymptomatic GC 
GC-contact; negative GC 
cultures 
No GC (contact); negative 
GC cultures 
Total 
No previous GC 
42 
18 
86 
146 
Previous GC Total 
10 52 
8 26 
18 104 
36 182 
few months to years. The prevalence of gonorrhoea in the group without a 
history of gonorrhoea was the same as thatin the entire group ( 42/146=29% ). 
ELISA absorbance values 
Figure 1 shows the ELISA absorbance values in the various groups of 
patients. Accepting the absorbance value A;:;o0.85 (initially established as 
breakpoint in this ELISA)' as the boundary between positive and negative, 
sera from females with asymptomatic gonorrhoea were positive in 38/ 
52=73%; the corresponding figures for gonorrhoea contacts and for the 
remainder were 13/26=50% and 36/104=35%, respectively. At the various 
other absorbance breakpoints the corresponding sero-positive ELISA results 
were calculated (table 2). Of course sensitivity decreased and specificity in-
Table 2 Sero-positive results at different ELISA absorbance breakpoints in 182 
asymptomatic females attending an STD clinic. 
Absorbance 
breakpoint 
;;,0.85 
>1.00 
~1.15 
:;;,1.30 
Asymptomatic 
GC 
(n=52) 
38 (73)* 
34 (65) 
32 (62) 
29 (56) 
Groups of patients 
GC-contact; 
negative GC 
culture 
(n=26) 
13 (50) 
12 (46) 
10 (38) 
10 (38) 
* percentage of positive sera in brackets. 
70 
No GC (contact); 
negative GC 
culture 
(n=104) 
36 (35) 
30 (29) 
19 (18) 
14 (13) 
AS GC 
n= 52 
A {492 nm) 
2.00 
1. 75 
1. 25 
1. 00 
0.75 
~ 0.50 
Fig I 
GC contact 
negative cultures 
n=26 
.. 
No GC{contact) 
negative cultures 
n"'104 
.. 
I' 
:·:·· 
... 
'I'" .. 
•'•' 
i•'• !:' 
...... 
'I'" lo0o 
. .... 
ELISA absorbance values in 182 asymptomatic females attending an STD clinic. 
AS GC 
GC-contact 
No GC(contact) 
patients with asymptomatic gonorrhoea 
patients reporting as gonorrhoea contact with negative gono-
coccal cultures 
patients not reporting as gonorrhoea contact and not suffering 
from gonorrhoea 
creased as the breakpoint was raised (tables 2 and 3). A striking finding was 
that in the group of gonorrhoea contacts the number of positive sera did not 
diminish evenly, and that even at breakpoint A?o-1.30 38% ofthese sera were 
still positive. 
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Table 3 Sensitivity, specificity and predictive values of a positive [PV( +)]and of a 
negative [PV(-)] result at different ELISA absorbance breakpoints in 182 
asymptomatic females attending an STD clinic 
Absorbance Sensitivity % Specificity %* PV(+) PV(-) 
breakpoint 
;;;,0.85 73 62 0.44 0.85 
;;;,1.00 65 68 0.45 0.83 
;;;,1.15 62 78 0.52 0.83 
;;;, 1.30 56 82 0.55 0.82 
* including gonorrhoea contacts. 
The predictive value of a pos1l!ve result was highest at A;;,1.30 
(PV(+)=0.55) but it exceeded 50% even at A;;,1.15 (PV(+)=0.52). The 
predictive value of a negative result was highest at A>0.85 (PV(-) =0.85). 
Females without a history of gonorrhoea 
Tables 4 and 5 present, in the same way as for the entire group of females, 
the results of the ELISA and their predictive values in asymptomatic females 
without a history of gonorrhoea. Comparison of tables 3 and 5 shows that the 
sensitivity is not influenced by previous gonococcal infections. The specificity 
increases slightly when females with a history of gonorrhoea are excluded. 
Table 5 shows that the predictive value of a positive result is highest at 
A>l.15 (PV( +) =0.57), and that of a negative result at A;?>0.85 
(PV(-) =0.87). 
Table 4 Sero-positive results at different ELISA absorbance breakpoints in 146 
asymptomatic females withouJ a history of gonorrhoea attending an STD 
clinic 
Absorbance 
breakpoint 
;;;,0.85 
;;;, 1.00 
:;,1.15 
:;,1.30 
Asymptomatic 
GC 
(n=42) 
31 (74)* 
28 (67) 
26 (62) 
20 (48) 
Groups of patients 
GC-contact; 
negative GC 
culture 
(n=18) 
9 (50) 
9 (50) 
9 (50) 
9 (50) 
* percentage of positive sera in brackets. 
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No GC (contact); 
negative GC 
culture 
(n=86) 
23 (27) 
18 (21) 
11 (13) 
9 (10) 
Table 5 Sensitivity, specificity and predictive values of a positive [PV( +)]and of a 
negative [PV(-)] result at different ELISA absorbance breakpoints in 146 
asymptomatic females without a history of gonorrhoea attending an STD clinic 
Absorbance Sensitivity % Specificity % * PV(+) PV(-) 
breakpoint 
;>0.85 74 69 0.49 0.87 
;>1.00 67 74 0.51 0.85 
~1.15 62 81 0.57 0.84 
;>1.30 48 83 0.53 0.80 
* including gonorrhoea contacts. 
Discussion 
Serological tests using gonococcal pili as antigen are highly sensitive in 
females with asymptomatic gonorrhoea. Buchanan et al.1 attained a sensitivity 
of 89% with the RIA, and Oates et al. 2 attained 85% with the same test. 
The incidence of asymptomatic infections in females with uncomplicated 
gonorrhoea attending an STD clinic is about 40-60%.9 
The aim of this study was to establish what the value of the ELISA 6650 
would be in the diagnosis of gonorrhoea in asymptomatic females if various 
absorbance breakpoints were considered in the test. Four breakpoints were 
arbitrarily chosen. With the aid of sensitivity, specificity and prevalence figu-
res, the corresponding predictive values for a positive and for a negative result 
(PV( +)and PV(- )) were calculated. The best PV( +)was attained atA;;;,1.15 
and A;;;,1.30, and the best PV(-) at A;;;,0.85. 
Of the patients studied, 20% had no history of gonorrhoea. When these 
were excluded, the PV(+) rose only at A;;;,1.15 (not at A;;;,1.30) and the 
PV(-) rose slightly. 
As previously demonstrated (chapter 6) and illustrated in this paper, pre-
viously acquired gonorrhoea influences especially the specificity of tests using 
pili, and exerts a less marked influence on sensitivity, even if the previous 
gonorrhoea was acquired years ago. 
There was a difference in specificity between patients reporting as go-
norrhoea contact and the other patients with negative cultures. Young and 
Low10, also using an ELISA with gonococcal pili as antigen, likewise found 
more positive test results in females reporting as gonorrhoea contact than in 
the other females with negative cultures. Among females reporting as gonor-
rhoea contact, there were undoubtedly a few culture failures. These patients 
were often treated on basis of the history, and in many cases, therefore, only 
one culture was made before treatment. 
In a retrospective study of 210 females with gonorrhoea (cultured only from 
cervix and urethra), Evans11 found that the diagnosis was missed at the first 
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examination in 10%. Moreover, at least a few percents of the gonococcal 
strains do not grow on the selective nutrient medium used here7 And finally, 
false negative results may be obtained due to irrigation of the vagina with 
bacteriolytic or bactericidal solutions and due to umeported use of antibiotics. 
It can be stated in summary that, for use in asymptomatic females attending 
an STD clinic, the ELISA can be interpreted as follows. The result is positive at 
A;?l.l5, and negative at A <0.85, at which absorbances PV( +) =0.52 and 
PV(- )=0.85. When results are between A=0.85 and A= 1.15, a new blood 
sample should be taken and the test repeated. 
This version of the ELISA provides some help in the diagnosis of gonor-
rhoea in asymptomatic females attending an STD clinic. 
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CHAPTER 10 
General Discussion 
Gonorrhoea is a sexually transmitted disease with a brief period of incuba-
tion. Females with asymptomatic infections are considered to be an important 
source of the spread of gonorrhoea. The development of a sensitive, specific 
serological test could be an important aid in the detection of gonorrhoea in this 
group and in other groups of patients. In this respect the GCFT using an 
impure antigen has not been satisfactory. 
In recent years attempts have been made to enhance the sensitivity and 
specificity of tests for detection of gonorrhoea by using purified antigens such 
as pilP-3, outer membrane protein4 and, very recently, ribosomal fract:i,ons. 5 
Highly sensitive test systems such as RIA', ELISA'- 4 and !HA3• 5 have been 
applied. 
In this study pili of various gonococcal strains were prepared and pnrified for 
use as antigens. Paired sera and corresponding gonococcal strains were col-
lected from patients with gonorrhoea attending an STD clinic, and sera were 
collected also from patients without gonorrhoea. Using pili prepared from 
strain 1443 as antigen, the value of taking paired sera was studied with the aid 
of an ELISA (ELISA 1443). It was found that, in males and females with 
uncomplicated gonorrhoea, the sensitivity of the assay rises when paired sera 
are tested. A relatively high sensitivity ( 61%) was attained in females with 
asymptomatic infections, but in this group the testing of the second serum did 
not further enhance sensitivity. 
Next, the ELISA 1443 was compared with the IHA 2686 and with the 
GCFT routinely used in The Netherlands, with whole gonococci of a single 
strain (Oliver) as antigen. The pili in the IHA 2686 were prepared from an 
American strain originally used by Buchanan et al.' The ELISA 1443 and the 
IHA 2686 hardly differed in sensitivity and specificity. The sensitivity of the 
three tests was highest in oropharyngeal gonorrhoea and gonorrhoea! com-
plications. The two assays using pili were much more sensitive than the GCFT. 
The specificity of all tests was very high in low-risk groups; in high-risk groups, 
however, the GCFT seemed more specific. The specificity of the pilus assays 
was influenced somewhat unfavourably by previous gonococcal infections. 
The antigenic heterogeneity of gonococcal pili in human sera was studied 
with the aid of IHA inhibition tests. For this purpose, purified pilus prepara-
tions were prepared from gonococci isolated from patients. The sera from 
these patients were tested with antigen of the homologous strain as well as with 
pili of strain 2686. Among 22 pilus preparations examined, pili of two strains 
were found to differ in antigenic properties from each other as well as from pili 
of strain 2686. An important finding was that, with pili of strain 6650 (one of 
these preparations), the IHA attained a significantly higher sensitivity in 
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females with uncomplicated gonorrhoea (71%) than could he attained with 
pili of strain 2686. The sensitivity in the subgroup of females with asympto-
matic infections was even as high as 75%. In the ELISA, too, pili of strain 6650 
(ELISA 6650) scored significantly higher than strain 1443 pili. 
Finally, the diagnostic value of the ELISA 6650 was studied in asympto-
matic females attending an STD clinic. A study was made of the influence of a 
shift in absorbance breakpoint on the sensitivity and specificity of the test. It 
was found that the ELISA 6650 could be of some help in the diagnosis of 
asymptomatic gonococcal infections in females. The sensitivity and specificity 
of this pilus assay, however, are still far from optimal. 
It can be concluded that the use of pilus assays markedly improves the 
serological diagnosis of gonorrhoea if compared with the GCFT as routinely 
used in The Netherlands. Yet in their present form these tests are not very 
suitable as a diagnostic aid in STD clinic populations. Their sensitivity is 
insufficient and their specificity too low. However, the pilus assays are suitable 
as a diagnostic aid in examining patients suspected of complicated gonococcal 
infections. Unfortunately, the specificity of the tests is insufficient in these 
cases, too, due to persistence of antibodies to gonococcal pili after previous 
gonococcal infections. The sensitivity and specificity of pilus assays might be 
improved by selection of pilus preparations of broader antigenic composition. 
This, however, should not lead to cross-reactions with meningococci or other 
Neisseria species. 
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Summary 
In The Netherlands, the gonococcal complement fixation test (GCFT) is 
commonly used in the serological diagnosis of gonorrhoea. This test is valuable 
in complicated forms of gonorrhoea but in uncomplicated forms it is unsatis-
factory due to insufficient specificity and in particular insufficient sensitivity. 
The GCFT uses a crude antigen prepared from a particular strain by ex-
traction. 
In an effort to improve serodiagnosis, this thesis studies the way in which, in 
a gonococcal infection, antibodies are produced to a particular antigen at the 
surface of gonococci, i.e: pili. For this purpose gonococcal pili were purified 
and used in highly sensitive serological systems such as the enzyme-linked 
immunosorbent assay (ELISA) and the indirect haemagglutination assay 
(IHA). Paired sera and corresponding gonococcal strains were collected from 
patients with several forms of gonorrhoea; paired sera were also obtained from 
patients without gonorrhoea. On the basis of history, sex and diagnosis, the 
patients were divided into well-defined groups. Sera obtained on the day of the 
first examination (D1) and sera generally obtained 11-22 days later (D2) were 
examined. 
Chapter 1 presents a brief historical review of the discovery of Neisseria 
gonorrhoeae and a general introduction which discusses the identification, 
cellular wall composition and typing of the bacterium. 
Chapter 2 presents a survey of the literature on serological tests used to 
detect gonorrhoea and discusses the principal problems in the development of 
serological tests, e.g. gonococcal heterogeneity, persistence of antibodies from 
previous gonococcal infections, and cross-reactions with other Neisseria spe-
Cies. 
Chapter 3 describes the aims and the design of the study presented in this 
thesis. 
Chapter 4 discusses the techniques used to purify pili and describes the 
procedure of the ELISA. 
Chapter 5 discusses the value of testing paired sera from patients with and 
without gonorrhoea by means of the ELISA with pili 1443 as antigen (ELISA 
1443). In the groups of males and females with uncomplicated gonorrhoea, the 
use of a second serum sample distinctly enhanced the sensitivity of the test. In 
the group of females with asymptomatic infections it did not. The choice of the 
absorbance breakpoint in the test is discussed in an appendix to this chapter. 
Chapter 6 describes a comparative study of the ELISA 1443, the GCFT 
routinely used in The Netherlands, and the IHA with pili 2686 as antigen (IHA 
2686) in patients with and without gonorrhoea. In females with uncomplicated 
gonorrhoea the maximum sensitivity was 53% with the ELISA 1443, 58% 
with the IHA 2686 and 22% with the GCFT. The corresponding figures in 
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males with uncomplicated gonorrhoea were41 %, 50% and 14%, respectively. 
The three tests showed a high specificity in low-risk groups; in high-risk groups 
the specificity of the GCFT seemed to be higher. 
Chapter 7 demonstrates the antigenic heterogeneity of gonococcal pili using 
human sera in the test system on the basis of indirect haemagglutination 
inhibition studies. With pili 6650 as antigen in the IHA (IHA 6650), a 
significant increase in sensitivity was observed in females with uncomplicated 
gonorrhoea if compared with the IHA 2686. In females with asymptomatic 
uncomplicated gonorrhoea the maximum sensitivity in the IHA 6650 was 
75%. 
Chapter 8 compares gonococcal pili 1443 and 6650 as antigen in the ELISA 
system. In females with uncomplicated gonorrhoea the sensitivity of the 
ELISA 6650 significantly exceeded that of the ELISA 1443 and equalled that 
of the IHA 6650. 
Chapter 9 discusses the diagnostic value of the ELISA 6650 in asymptoma-
tic females with and without gonorrhoea. When several absorbance 
breakpoints are used in the system, the ELISA 6650 can be of some help in the 
diagnosis of gonorrhoea in this patient group. Thus interpreted, the predictive 
value of a positive result [PV( +)lis 0.52, and that of a negative result [PV(-)l 
is 0.85. 
Chapter 10 presents a general discussion and the principal conclusions from 
the study described in this thesis. In their present form, pilus assays are not 
quite suitable for use in STD clinic populations. The sensitivity of these assays 
is high in oropharyngeal gonorrhoea and gonorrhoea! complications. They are 
an important diagnostic aid when gonorrhoea! complications are suspected. 
The search for new, better pilus antigens should take into account the broad 
antigenic composition and heterogeneity of gonococcal pili; it should also 
establish whether cross-reactions with other Neisseria species occur, and 
whether previous gonococcal infections exert an unfavourable influence on 
specificity. 
In this respect it should be borne in mind that the manner in which (as in this 
study) the gonococci and corresponding sera are collected and used is of 
essential importance for rapid and reliable comparison of antigens. 
Samenvatting 
In Nederland wordt voor de serologische diagnostiek van gonorroe als regel 
de gonococcen complement fix a tie test (GCFT) toegepast. Deze test is we! van 
waarde bij gecompliceerde vormen van gonorroe, maar bij ongecompliceerde 
vormen van deze infectie voldoet deze test niet door gebrek aan specificiteit en 
vooral ook door een gebrek aan sensitiviteit. In de GCFT wordt gebruik 
gemaakt van een ruw antigeen, dat door extractie word! bereid uit een bepaal-
de stam. 
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Met bet doe! de serodiagnostiek te verbeteren, word! in dit proefschrift 
onderzocht hoe bij een gonorroische infectie de antilichaamvorming verloopt 
tegen een bepaald antigeen aan bet oppervlak van gonococcen n.l. pili. Daar-
toe werden gonococcen pili gezuiverd en in zeer gevoelige serologische syste-
men zoals de enzyme-linked immunosorhent assay (ELISA) en de indirecte 
hemagglutinatie reactie (IHA) toegepast. Van patienten met gonorroe werden 
gepaarde sera en bijbehorende gonococcenstammen verzameld. Ook werden 
sera verzameld van patienten zonder gonorroe. De patienten werden op grond 
van anamnese, geslacht en diagnose ingedeeld in goed gedefinieerde groepen. 
Sera afgenomen op datum van eerste onderzoek (DI) en in bet algemeen 
11-22 dagen later (D2) werden onderzocht. 
In een algemene inleiding word! naast een kort historisch overzicht van de 
ontdekking van Neisseria 'gonorrhoeae, ingegaan op identificatie, celwandsa-
menstelling en typering van de hacterie (hoofdstuk 1 ). 
Vervolgens word! een literatuuroverzicht betreffende serologische testen 
ter detectie van gonorroe gegeven (hoofdstuk 2). De voornaamste problemen 
bij de ontwikkeling van serologische testen zoals gonococcen heterogeniteit, 
persisteren van antilichamen t.g.v. vroegere gonococcen infecties en 
kruisreacties met andere Neisseria worden genoemd. 
Na heschrijving van de doelstelling en opzet van de studie (hoofdstuk 3), 
worden in hoofdstuk 4 methoden besproken, die werden gebruikt bi j de 
zuivering van pili en wordt de methodiek van de ELISA beschreven. 
De waarde van bet testen van gepaarde sera bij patienten met en zonder 
gonorroe m.b.v. de ELISA met pili 1443 als antigeen (ELISA 1443) word! in 
hoofdstuk 5 beschreven. Bij de groepen vrouwen en mannen met ongecom-
pliceerde gonorroe gafhet bepalen van een tweede gepaard serummonster een 
duidelijke toename van de sensitiviteit te zien. By asymptomatisch ge'infec-
teerde vrouwen gaf het testen van het tweede serummonster geen extra 
bijdrage in de sensitiviteit. In de appendix van dat hoofdstuk word! ingegaan 
op de keuze van bet breekpunt in de test. 
Dan word! een vergelijkend onderzoek tussen de ELISA 1443, de in Ne-
derland routinematig in gebruik zijnde GCFT en de indirecte hemagglutinatie 
reactie met pili 2686 als antigeen (IHA 2686) beschreven bij patienten met en 
zonder gonorroe (hoofdstuk 6). De maximale sensitiviteit bij vrouwen met 
ongecompliceerde gonorroe bedroeg 53% hij de ELISA 1443, 58% in de IHA 
2686 en 22% in de GCFT. Bij mannen met ongecompliceerde gonorroe was 
de sensitiviteit resp. 41% in de ELISA 1443,50% in de IHA 2686 en 14% in 
de GCFT. Bij low-risk groepen hebben de drie testen een hoge specificiteit, bij 
high-risk groepen lijkt de specificiteit van de GCFT boger te zijn. 
Antigene heterogeniteit van gonococcen pili met gebruik van humane sera 
in bet test systeem werd gedemonstreerd door middel van indirecte hemag-
glutinatie inhibitie studies (hoofdstuk 7). Met pili 6650 als antigeen in de IHA 
(IHA 6650) werd een significante verhoging van de sensitiviteit bereikt bij 
vrouwen met ongecompliceerde gonorroe t.o.v. die van de IHA 2686. Bij 
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vrouwen met asymptomatisch ongecompliceerde gonorroe bedroeg de sensiti-
viteit in de IHA 6650 maximaal 75%. 
In hoofdstuk 8 worden gonococcen pili 1443 en 6650 als antigeen in het 
ELISA systeem met elkaar vergeleken. Bij vrouwen met ongecompliceerde 
gonorroe is de sensitiviteitvan de ELISA 6650 significant hager dan die van de 
ELISA 1443 en gelijk aan die van de IHA 6650. 
De diagnostische bruikbaarheid van de ELISA 6650 bij asymptomatische 
vrouwen met en zonder gonorroe, wordt in hoofdstuk 9 beschreven. Met het 
toepassen van meerdere breekpunten in het testsysteem kan de ELISA 6650 
van enig nut zijn bij de diagnostiek van gonorroe bij deze patientengroep. Op 
deze wi jze geinterpreteerd is de predictieve waarde van een positief resultaat 
PV( + )=0.52 en van een negatief resultaat PV(- )=0.85. 
Hoofdstuk 10 bevat een algemene discussie, waarin de belangrijkste con-
clusies van het in dit proefschrift beschreven onderzoek staan vermeld. Pilus-
assays zi jn in hun huidige vorm weinig geschikt voor toepassing bij geslachts-
ziektenpolikliniek populaties. De sensitiviteit van de testen is hoog bij orop-
haryngeale gonorroe en gonorroische complicaties. Bij verdenking op gonor-
roische complicaties zijn ze een belangrijk diagnostisch hulpmiddel. Bij het 
zoeken naar nieuwe en betere pilus antigenen dient men rekening te houden 
met de breedte van de antigene samenstelling en heterogeniteit van gonococ-
cen pili; ook dient men na te gaan of er kruisreacties met andere Neisseria 
optreden en of er een nadelige invloed van vroeger doorgemaakte gonorrol-
sche infecties op de specificiteit is. Daarbij is de manier, waarop gonococcen en 
daarbij behorende sera, zoals in dit proefschrift, verzameld en gebruikt wor-
den, van essentieel belang om op snelle en verantwoorde wijze antigenen met 
elkaar te vergelijken. 
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